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Although the efficacy of group Cognitive-Behavioural Therapy (GCBT) is well documented, the 
mechanisms by which this therapy works are not well understood.  Evaluating mediators and 
moderators of symptom change during therapy is an important step in the process of identifying 
the mechanisms that contribute to symptom change (Kazdin, 2007).  Two studies were 
conducted in order to elucidate the process of symptom change within GCBT and to better 
understand how mediation of change during GCBT was evaluated in recent literature.  The first 
study consisted of adults (N = 15) attending transdiagnostic GCBT for anxiety, whereby clients 
with different anxiety presentations were treated in the same group. The efficacy of this therapy 
group was evaluated, and cognitive change was examined as a potential mediator of symptom 
change.  Results did not indicate significant symptom improvement, and the mediation 
hypothesis was not supported.  The small sample size is a prominent limitation that may have 
contributed to the lack of statistically significant findings.  The second study consisted of a 
systematic review of recent literature to determine how mediation is assessed during GCBT.  A 
total of 30 studies met inclusion criteria, and were rated based on when potential mediators and 
outcomes were assessed.  The most frequently used design measured outcomes and mediator 
variables at pre- and post-treatment only, which is a design that cannot determine the time 
sequence of change.  Though many studies have investigated mediation, research designs that 
can truly identify a mediator have rarely been used.  Together, the findings of the present studies 
highlight the need for future research to investigate mediation with more rigorous designs, while 
also using samples that are sufficient enough in size and representativeness to provide important 
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Mechanisms of Change within Group Cognitive-Behavioural Therapy for Anxiety 
 
Cognitive-behavioural therapy (CBT) is a psychotherapy emphasizing thought 
restructuring and coping skills development (Portman, 2009) that has been rigorously tested in 
randomized controlled trials (RCTs). While the results of RCTs for individually delivered, 
disorder specific CBT are critical to investigating the efficacy of a therapy, it is also important to 
evaluate treatment formats that are frequently used in clinical settings.  As group treatment 
formats are often utilized to deliver therapy in “real-world” settings, GCBT is the focus of this 
paper.  Meta-analyses have supported the efficacy of GCBT in treating symptomatology related 
to various disorders, including but not limited to depression (Oei & Dingle, 2008), anxiety (Hans 
& Hiller, 2013; Stewart & Chambless, 2009), Irritable Bowel Syndrome (IBS; Li, Xiong, Zhang, 
Yu, & Chen, 2014), and substance use (Magill & Ray, 2009).  Evidently, GCBT is an efficacious 
treatment format. 
However, the processes by which GCBT exerts its effects are less clear.  For example, 
group factors such as the group dynamics or cohesion could impact the extent to which one 
benefits from treatment, along with the impact of the CBT components.  Different process 
variables may influence the effect of treatment, depending on the disorder or symptoms being 
treated.  As GCBT may contain some process variables that differ from those in individual CBT, 
and this treatment format is commonly used in clinical settings, this thesis aimed to elucidate the 
processes that lead to change over the course of GCBT and how processes of change are 
assessed. More specifically, this thesis sought to gain a better understanding of both how change 
occurs in GCBT for anxiety, and how change is measured within GCBT for any disorder. 
In order to achieve these two objectives, two studies were conducted.  The first study 
focused on transdiagnostic GCBT for anxiety in order to examine a potential mechanism of 
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change within this specific type of therapy.  The second study examined how mediation is 
established in current literature, and explored the mediators of GCBT that have been evaluated. 
Thus, the second study examined how mediation is assessed more generally, across GCBT for 
various diagnoses, as opposed to solely focusing on GCBT for anxiety.  Within both studies, 
Kazdin’s (2007) recommendations for assessing mechanisms of change were utilized.  Kazdin 
asserted that the active mechanisms within therapy could begin to be understood by first 
investigating mediation. 
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Anxiety disorders are highly prevalent among the population and may negatively affect 
one’s quality of life.  The National Comorbidity Survey Replication in the United States 
determined that anxiety disorders were the most prevalent psychiatric disorder, with 18.1% of 
the population meeting criteria for an anxiety disorder (Kessler, Chiu, Demler, & Walters, 2005). 
Similarly, the one-year prevalence rate of anxiety disorders among adults in Ontario was 12% 
between 1990 and 1991 (Offord et al., 1996).  The prevalence of anxiety may be even greater 
when considering individuals with anxiety symptoms who do not meet criteria for a disorder.  In 
addition to their high prevalence, anxiety disorders are also highly troubling for individuals. 
Anxiety disorders may negatively affect one’s quality of life (Saarni et al., 2007) to an extent that 
is comparable to the impact of chronic medical conditions (Lépine, 2002). Furthermore, anxiety 
disorders engender significant economic costs for individuals and society (Koerner et al., 2004; 
Rice & Miller, 1998).  There were 11 anxiety disorders described within the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), which 
included: panic disorder with and without agoraphobia, specific phobia, social phobia, obsessive- 
compulsive disorder (OCD), posttraumatic stress disorder (PTSD) and generalized anxiety 
disorder (GAD; American Psychiatric Association [APA], 2000).  These anxiety disorders are 
still included in the fifth edition of this manual (DSM-5), though they are now separated into the 
categories of Anxiety Disorders, Obsessive-Compulsive and Related Disorders, and Trauma- and 
Stressor-Related Disorders (APA, 2013). The high prevalence, debilitating nature and economic 
burden of anxiety disorders indicate a need for these symptoms to be addressed and alleviated. 
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Consequently, it is important for efficacious treatments to be delivered and easily 
accessed by people experiencing symptoms of anxiety or depression.  Randomized controlled 
trials testing the efficacy of psychotherapies for emotional disorders have primarily focused on 
disorder-specific protocols and the outcomes regarding that particular disorder.  Meta-analyses of 
these studies have consistently supported the efficacy of CBT in treating anxiety disorders 
(Hoffman & Smits, 2008; Norton & Price, 2007).  Moreover, CBT has demonstrated superiority 
over wait-list control groups and placebos for the treatment of anxiety disorders (Olatunji, Cisler, 
& Deacon, 2010).  Though the utility of diagnosis-specific CBT has been well supported, recent 
research has suggested alternative benefits to treating patients with various anxiety disorders in a 
single CBT group, largely due to the feasibility of such a format. The study of transdiagnostic 
treatments is relatively nascent, creating a need to determine how this approach may be useful. 
Thus, the present study examined the utility of transdiagnostic GCBT in treating anxiety and 
depressive symptoms, while also exploring the active mechanisms within the therapy. 
Transdiagnostic Theory 
Rather than targeting a specific disorder, transdiagnostic treatments are broad therapy 
protocols that apply the same treatment principles to a diagnostically heterogeneous group 
(McEvoy, Nathan, & Norton, 2009).  Transdiagnostic treatments are based on the idea that 
shared features exist across disorders and that these commonalities are greater than the 
differences between disorders (McEvoy et al., 2009). There appear to be many commonalities 
among anxiety and mood disorders, making transdiagnostic treatment possible.  These 
commonalities are highlighted by McEvoy et al. (2009) as well as other authors, and include: 
shared clinical features (McManus, Shafran, & Cooper, 2010), comorbidity (Barlow, Allen, & 
Choate, 2004), shared maintaining processes (McManus et al., 2010), common underlying 
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constructs (Clark & Watson, 1991), and similar biological and psychological vulnerabilities 
 
(Andrews, 1991; Kendler, Heath, Martin, & Eaves, 1987). 
 
Shared Features. There are some shared clinical features across the anxiety disorders, as 
they are commonly characterized by an overestimation of threat, avoidance, and physiological 
arousal (McManus et al., 2010).  Beck (1976) asserts that overestimation of the possibility and 
dangerousness of threat is common across anxiety disorders.  Fear often accompanies this 
perception of threat.  Several anxiety disorders reflect the presence of fear.  For example, the fear 
of a certain object may be associated with specific phobia, the fear of having panic attacks is 
related to panic disorder, and a fear of a specific event that is addressed with a compulsion can 
be present in OCD (APA, 2000).  Worry is another shared clinical feature that pertains to an 
individual’s perception of threat.  Though worry is present across disorders, it is the focus of the 
worry that differentiates anxiety disorders from one another.  For example, people with social 
phobia may worry about embarrassment, people with GAD may worry about everyday things 
and people with OCD may worry about contamination (Barlow, 2002).  However, there are some 
instances when the same worry can be present among different disorders.  For example, some of 
the worries held by an individual with GAD could relate to physical symptoms, yet worry in this 
domain could also be associated with panic disorder (McManus et al., 2010).  The fear and worry 
associated with an overestimation of threat can be shared features across the anxiety disorders. 
In addition to overestimation of threat, anxiety disorders are often characterized by 
avoidance and physiological arousal.  The core criteria for agoraphobia, social phobia, specific 
phobia, and PTSD include avoidance of a particular situation (APA, 2000).  Avoidant behaviours 
may also be demonstrated in other anxiety disorders where the avoidance is not included in the 
diagnostic criteria.  The physiological arousal associated with anxiety disorders may be 
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manifested as sweating, trembling or shaking, heart palpitations, or dizziness.  The experience of 
such physiological symptoms is included in the criteria for panic attacks, which can be 
associated with several anxiety disorders, depending on the context of the attacks (APA, 2000). 
Arousal associated with anxiety disorders may also include symptoms such as hypervigilance 
and difficulty sleeping, as seen with PTSD (APA, 2000).  Therefore, avoidance and symptoms of 
physiological arousal are evident among many anxiety disorders. 
Along with the features that characterize anxiety disorders, there are some other shared 
symptoms across the disorders.  Symptoms such as unwanted thoughts, recurrent images, and 
checking behaviours can be present in several anxiety disorders (Huppert et al., 2005; McManus 
et al., 2010; Schut, Castonguay, & Borkovec, 2001).  Also, physical conditions such as irritable 
bowel syndrome (Gros, Antony, McCabe, & Swinson, 2009), respiratory illnesses, and vestibular 
abnormalities (Barlow, 2002) are frequently associated with several of the anxiety disorders. 
Evidently, there is high overlap among the symptoms and associated features of anxiety 
disorders.  The DSM-IV-TR criteria reliably discriminate between anxiety disorders, but there is 
sometimes diagnostic disagreement due to the overlapping symptoms (Brown, DiNardo, 
Lehman, & Campbell, 2001). Additionally, there are some shared features of anxiety and mood 
disorders, which may also relate to diagnostic disagreements (Brown et al., 2001).  For example, 
GAD and depression share some symptoms such as fatigue, difficulty sleeping, and restlessness 
(Brown, Chorpita, & Barlow, 1998).  Therefore, the symptom and diagnostic overlap among 
various anxiety and mood disorders indicates that commonalities exist among these disorders. 
Comorbidity.  Anxiety disorders are often comorbid with other Axis I disorders.  In their 
study of adult outpatients seeking assessment and treatment at mental health centres, Brown, 
Campbell, Lehman, Grisham, and Mancill (2001) found that 55% of patients with a primary 
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anxiety diagnosis had a comorbid mood or anxiety disorder. Therefore, comorbidity appears to be 
more common than the presentation of a single anxiety disorder (Brown et al., 2001).  The 
common co-occurrence of anxiety disorders and other Axis I disorders has also been indicated 
among adult patients presenting at a centre for anxiety disorders.  Using structured diagnostic 
interviews, Sanderson, DiNardo, Rapee, and Barlow (1990) determined that 70% of the patients 
with an anxiety disorder also had another Axis I disorder.  Specifically, a mood disorder was the 
additional diagnosis for 33% of the patients (Sanderson et al., 1990).  Along with the frequent 
comorbidity of disorders for patients with anxiety disorder diagnoses, mood disorders appear to 
commonly co-occur with anxiety.  Barlow et al. (2004) suggested that comorbidity may be a 
function of the overlap between diagnostic categories or it may be due to a solitary construct 
underlying these disorders.  In the latter possibility, the presence of one disorder may increase 
one’s risk of experiencing another disorder.  Shared maintaining factors could also contribute to 
comorbidity.  The high prevalence of comorbidity among anxiety and mood disorders supports 
the use of transdiagnostic group treatment from a practical perspective, since numerous disorders 
could be addressed with a unified treatment.  The transdiagnostic approach is further supported 
as it may act upon the common constructs that lead to high comorbidity. 
 
Common maintaining processes. Evidence has been generated to support the existence 
of common maintaining processes across anxiety and mood disorders.  In a meta-analysis 
examining threat-related attentional biases, Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, 
and Van Ijzendoorn (2007) found that there is a similar bias among individuals with anxiety 
disorders, regardless of the presence of depression.  This attentional bias consists of a tendency 
to pay greater attention to stimuli that are threat-related, compared to stimuli that are neutral. 
There is currently no consensus regarding the exact mechanisms that account for this bias, as 
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researchers have proposed various cognitive possibilities such as an automatic tendency to notice 
threats or a heightened inability to ignore threats.  Nevertheless, this meta-analysis examining 
172 studies indicates that threat-related bias is a robust phenomenon across the anxiety disorders, 
as it has been demonstrated with various experimental manipulations as well as across various 
populations.  Furthermore, the attentional bias is not evident among individuals without anxiety. 
Bar-Haim and colleagues (2007) speculated that these results indicate a common component 
across anxiety disorders and symptoms of anxiety. 
In addition to attentional bias, interpretational, reasoning, and thinking biases have been 
identified as common processes among some anxiety disorders (Harvey, Watkins, Mansell, & 
Shafran, 2004).  Interpretational bias consists of interpreting ambiguous stimuli in an overly 
negative fashion.  This bias has been demonstrated across some of the anxiety disorders such as 
panic disorder, social phobia, PTSD, and GAD (Harvey et al., 2004).  Similarly across some 
anxiety disorders, there is evidence of expectancy and emotional reasoning biases.  Expectancy 
biases consist of an overestimation of the possibility that a negative event will occur, while 
emotional reasoning biases consist of making conclusions about the likelihood of adverse events 
based on one’s emotional state (Harvey et al., 2004).  When an individual’s thinking is 
influenced by their anxious state, it may exacerbate their expectancy for negative events.  As 
such, it is evident that these reasoning biases can maintain one’s anxiety. Additionally, Harvey 
and colleagues (2004) asserted that recurrent thinking in the form of worry or rumination over 
events and metacognitions where an individual reflects on their own thoughts, are common 
among anxiety disorders.  Continuous reflection on anxious thoughts likely perpetuates further 
anxious thinking.  Across various anxiety disorders, these interpretive, reasoning, and thinking 
biases appear to act as maintaining processes. 
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Along with the aforementioned cognitive processes, some behaviours that are widely 
demonstrated across anxiety disorders may maintain anxious symptoms or an individual’s 
cognitions.  Avoidance has been discussed as a shared feature across the anxiety disorders.  This 
behaviour may also act as a process that maintains anxiety, since individuals do not come in 
contact with their fears and so their perceptions of the fear are not altered.  Many people with 
anxiety disorders demonstrate safety behaviours that help them to cope with anxiety, which may 
also simultaneously maintain the underlying fear.  For example, an individual with a diagnosis of 
social phobia may avoid eye contact in social situations.  This behaviour would likely hinder the 
individual’s social interaction, thereby providing support for his/her negative thoughts about 
social interactions (Harvey et al., 2004).  Both cognitive biases and behaviours may act as 
maintaining mechanisms for various anxiety disorders.  While the content of cognitions and 
specific behaviours would differ and allow differentiation among the disorders, there is some 
evidence supporting the presence of similar general processes. 
Moreover, there may be similar neurological activation across some anxiety disorders. 
Etkin and Wager (2007) conducted a meta-analysis of studies utilizing functional magnetic 
resonance imaging and positron emission tomography imaging to investigate the brain regions 
that are active in individuals with anxiety.  Results indicated amygdalar and insular hyperactivity 
among patients with PTSD, social anxiety disorder and specific phobia in comparison to 
controls.  Though brain imaging also showed many differences in brain region activation among 
the disorders, the authors suggest that the common brain activation may be related to a similar 
neurobiological pathway for anxiety (Etkin & Wager, 2007).  Along with the evidence of 
common maintaining processes among the anxiety disorders, the common neurological 
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activation provides additional support for the idea of similar processes underlying anxiety 
disorders. 
Further evidence of common maintaining processes may be generated by the similar 
response of various anxiety disorders to the same treatment.  Barlow (2000) asserted that anxiety 
disorders have been empirically demonstrated to respond to CBT and pharmacotherapy, such as 
the use of selective serotonin reuptake inhibitors (SSRIs), to a comparable degree. Similarly, 
Ballenger (1999) proposes that the high effectiveness of cognitive restructuring and exposure 
components in therapy for various anxiety disorders, suggests the presence of shared maintaining 
processes.  If the same types of treatments influence change for different disorders, there are 
likely common processes or constructs underlying these disorders (Barlow, 2000). 
Underlying constructs.  Research has primarily focused on negative affect as a common 
construct underlying the anxiety and mood disorders.  Negative affect is the extent to which an 
individual experiences adverse mood states, such as feeling upset or guilty (Clark & Watson, 
1991).  It has been correlated to both diagnoses and symptoms of anxiety and depression 
(Watson, Clark, & Tellegen, 1988).  While studies have linked high negative affect to anxiety 
and depression (e.g., Hall, 1977; Tellegen, 1985; Watson, Clark, & Carey, 1988), low positive 
affect has been demonstrated to only relate to negative mood states (e.g., Tellegen, 1985; Watson 
et al., 1988).  These findings are reflected in the tripartite model proposed by Clark and Watson 
(1991), which suggests that negative affect is common to anxiety and depression, while high 
physiological arousal is unique to anxiety and low positive affect is unique to depression.  The 
model asserts that a single construct of negative affect underlies both anxiety and depression, 
while specific factors that are unique to anxiety and depression differentiate between these 
diagnostic categories.  Negative affect in the model is related to symptoms that are common to 
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both anxiety and depression such as poor concentration, restlessness or irritability (Watson et al., 
 
1995).  These common symptoms and affect may explain the high relatedness between 
depression and anxiety (Watson et al., 1995).  The low positive affect described in the model 
pertains to symptoms such as lacking energy and not feeling interested in anything, which are 
uniquely related to depression.  Contrarily, symptoms of physiological arousal such as feeling 
dizzy or experiencing trembling, are uniquely related to anxiety (Watson et al., 1995).  The 
tripartite model suggests that high negative affect can be indicative of the presence of anxious 
and depressive symptoms, but the exact presentation also depends on the presence of features 
that are specific to either anxiety or depression.  Thus, the affective domain cannot be understood 
by the shared or unique features of anxiety and depression in isolation from one another. Rather, 
it is the holistic view of the shared features (negative affect) and unique features (physiological 
arousal and lack of positive affect) that allow for a full understanding of affect (Clark & Watson, 
1991).  Support for the tripartite model has been generated through content analyses indicating 
that physiological arousal and lack of positive affect discriminate between anxiety and 
depression, as well as factor analyses demonstrating the presence of the three main constructs. 
Using the Mood and Anxiety Symptom Questionnaire (MASQ), the structure of items lends 
support to the tripartite model across undergraduate, adult, and clinical populations (Watson et 
al., 1995). 
The tripartite model has been extended into a hierarchical format.  This new hierarchical 
model consists of negative affect and positive affect as higher order factors, with paths that lead 
to specific diagnoses (Brown et al., 1998; Zinbarg & Barlow, 1996).  There are significant 
pathways from negative affect to mood disorders, GAD, OCD, panic disorder with or without 
agoraphobia (PDA), and social phobia and significant pathways from positive affect to only 
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mood disorders and social phobia (Brown et al., 1998).  This model also indicates paths from the 
lower order factor of autonomic arousal to PDA and GAD.  The previous view of negative affect 
as a blanket construct subsuming the anxiety disorders is extended in the hierarchical model 
through the specification of how positive and negative affect differentially relate to each 
diagnosis (Barlow et al., 2004). 
In further examination of higher order constructs relating to specific anxiety and mood 
disorders, Brown (2007) assessed outpatients at three time points over a two-year period to 
investigate the temporal relationship between the disorders and higher order constructs.  The 
results indicated that the covariance in self-reported scores related to GAD, depression, and 
social phobia was associated with the change in the self-reported measures of 
neuroticism/negative affect and behavioural inhibition (Brown, 2007).  It is possible that the 
symptoms associated with neuroticism/negative affect and behavioural inhibition were reduced 
with treatment, which led to a reduction in specific disorder symptoms.  However, causal 
conclusions are not possible due to the correlational nature of the findings.  Regardless of the 
exact causation, the results indicate that a decrease in disorder-related symptom severity is 
related to a reduction in neuroticism/negative affect and behavioural inhibition (Brown, 2007). 
These findings are consistent with previous indications of a common construct underlying the 
anxiety and mood disorders.  The existence of a shared construct is the overriding theme from 
these models.  This provides support for the use of a single treatment for multiple disorders that 
targets a common construct. 
Common Vulnerabilities.  The constructs underlying anxiety and mood disorders may 
imply a common vulnerability.  As neuroticism/negative affect and extraversion/positive affect 
are viewed as genetically based dimensions of temperament, they may have a role in the etiology 
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of anxiety and mood disorders (Brown, 2007).  In the study by Brown et al. (1998) analyzing 
higher order factors and their relation to specific disorders, findings suggested that the higher 
order constructs were related to the onset of anxious and depressive disorders.  Moreover, some 
research has suggested that a heritable component of neuroticism relates to the development of 
anxiety (e.g., Hettema, Prescott, & Kendler, 2004).  Further evidence of a shared etiology among 
anxiety and mood disorders is generated from twin studies.  Kendler et al. (1987) determined that 
genes have a non-specific effect in contributing to symptoms of anxiety and depression.  This 
suggests that there is a general genetic component that interacts with an individual’s life 
experiences and contributes to the development of anxiety or depression.  Thus, the genetic 
vulnerability factor is common to both anxiety and mood disorders (Kendler et al., 1987).  This 
finding coincides with theories proposing an underlying construct of negative affect.  Kendler 
and colleagues (1987) also determined that the environment has specific effects on the etiology 
of anxiety and mood disorders, by determining the specific symptom features that pertain to a 
particular diagnosis.  This suggests that there may be a general genetic vulnerability that is then 
expressed heterogeneously according to one’s experiences. 
Similarly, other authors have supported the presence of a common genetic vulnerability 
among the anxiety disorders.  Barlow (2000) suggested that biological and general psychological 
vulnerabilities relate to the development of GAD and depression, while biological, general 
psychological and specific psychological vulnerabilities contribute to the development of other 
anxiety disorders.  Though there are some factors that differentiate the specific symptom 
presentation, it is evident that a shared vulnerability factor contributes to the development of 
anxious and depressive symptoms. 
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Utility of Transdiagnostic Group CBT for Anxiety 
 
Efficacy and effectiveness.  The paradigms of efficacy and effectiveness are often used 
to determine if a therapy successfully produces a desired change and can be utilized in clinical 
practice.  The efficacy paradigm refers to whether observed differences are in fact due to the 
effects of the intervention, while the effectiveness paradigm refers to whether the therapy 
generalizes to a clinical setting (Erickson, 2003).  Treatment efficacy studies therefore analyze 
the therapy within ideal conditions, such as that of randomized controlled trials (RCTs). 
Treatment effectiveness studies evaluate the therapy within realistic clinical settings (Gartlehner, 
Hansen, Nissman, Lohr, & Carey, 2006). 
Studies analyzing the effectiveness of transdiagnostic CBT groups have produced 
encouraging results.  An improvement in self-reported anxiety symptoms following GCBT for 
heterogeneous anxiety groups has been demonstrated in several studies (e.g., Ellard, Fairholme, 
Boisseau, Farchione, & Barlow, 2010; Erickson, 2003; Garcia, 2004; Hooke & Page, 2002; 
Manning et al., 1994; McEvoy & Nathan, 2007; Norton, 2008; Norton & Hope, 2008; van Ingen 
& Novicki, 2009).  Reduction in depressive symptoms at post-treatment (McEvoy & Nathan, 
 
2007; Norton, Hayes, & Hope, 2004) and maintenance of symptom improvement at 6-month 
follow up (Ellard et al., 2010; Erickson, 2003; Manning et al., 1994) has also been demonstrated. 
While numerous studies have indicated symptom improvement following transdiagnostic GCBT, 
the few studies that used wait-list control groups produced less robust results.  Norton and 
Hope’s (2005) study involving 19 participants demonstrated significant symptom improvement 
in comparison to controls on clinician reports, but there was no improvement on patient self- 
report questionnaires.  A study conducted by Erickson, Janeck, and Tallman (2007) indicated 
significant improvement in self-reported anxiety severity symptoms post-treatment compared to 
MECHANISMS OF CHANGE WITHIN GCBT 15  
 
 
the waitlist control group.  However, when diagnosis and outcomes were analyzed, it appeared as 
though only patients with panic disorder experienced significant symptom improvement in 
comparison to the control group (Erickson et al., 2007).  A randomized controlled study of 23 
participants with primary anxiety disorders demonstrated significant improvement on self- 
reported depression symptoms following group CBT (Norton et al., 2004).  Though the 
aforementioned studies have shown symptom improvement in comparison to wait-list control 
groups, additional studies utilizing control groups are needed to examine the efficacy of 
transdiagnostic CBT groups. 
Currently, there is one study that has directly compared the efficacy of a transdiagnostic 
CBT group to a disorder-specific CBT group.  Norton and Barrera (2012) randomly assigned 
patients at an anxiety disorder clinic with diagnoses of panic disorder, social anxiety disorder or 
GAD to either transdiagnostic or diagnosis-specific treatment.  There were 23 participants in 
each of the treatment groups and both treatments consisted of 12 weekly two-hour sessions. 
Results indicated that there was significant improvement following treatment for both groups, 
however, the treatment groups did not differ significantly in their scores on self-reported 
symptom measures, clinician-rated measures, or perception of treatment credibility (Norton & 
Barrera, 2012).  Therefore, some preliminary evidence has been generated to support a similar 
efficacy of transdiagnostic and disorder-specific treatments for particular anxiety disorders. 
The comparable efficacy of transdiagnostic treatment to that of disorder-specific is 
important in gauging the utility of the treatment.  Transdiagnostic CBT is not intended to replace 
disorder-specific therapy (Clark, 2009), but it is still important to evaluate its efficacy in order to 
ensure that patients receive a treatment that has been empirically supported.  Mansell, Harvey, 
Watkins, and Shafran (2009) purport that transdiagnostic treatment should not be used if 
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disorder-specific treatment is just as efficient.  As disorder-specific treatments have been 
thoroughly empirically supported, there is no need to use a transdiagnostic approach if the 
disorder-specific therapy is available and feasible for the clinic.  However, transdiagnostic 
approaches may be more practical and efficient for some clinical settings.  In such a case, this 
format would be recommended.  The utility of transdiagnostic approach largely stems from its 
greater applicability to the average clinical setting.  If its efficacy is supported, then the other 
benefits associated with a unified approach may make this treatment more practical than 
disorder-specific treatments in some clinical settings. 
Applicability to clinical settings.  Rural and general mental health clinics may not have 
sufficient staff and resources to run different therapy groups for various disorders (Erickson, 
2009).  Such general clinics that do not specialize in the treatment of particular disorders are 
likely to have clients with various diagnoses (Clark, 2009; Erickson et al., 2007). The use of 
diagnostically heterogeneous treatment groups in these settings may promote client access to 
effective treatment (Erickson et al., 2007), while better suiting the clinic’s resources.   In fact, 
Erickson and colleagues (2007) suggest that transdiagnostic groups are more commonly utilized 
in general mental health clinics since these clinics are not likely to have enough clients with the 
same anxiety disorder who are available to participate in treatment at the same time.  If this 
heterogeneous group format is commonly used, then it is important for efficacy studies to be 
examining this format, in order to maximize the generalizability of empirically supported 
treatments to a clinical setting. 
Advantages of a transdiagnostic approach.  In addition to its applicability to a clinical 
setting, transdiagnostic treatment format offers other advantages.  Mansell et al. (2009) espouse 
the use of transdiagnostic CBT for reasons of parsimony and pragmatism.  A transdiagnostic 
MECHANISMS OF CHANGE WITHIN GCBT 17  
 
 
explanation of distress is believed to align with the scientific principle of parsimony, which 
refers to accepting the simplest explanation when possible (Mansell et al., 2009). Mansell and 
colleagues also reason that the pragmatic service delivery of a transdiagnostic treatment group 
supports its use.  There are several factors that contribute to the practicality of a transdiagnostic 
group.  Firstly, a unified treatment protocol may be more financially viable than single-service 
approaches to treatment.  Group therapy in general is often cost-effective since numerous clients 
are receiving treatment at once and only one manual is needed (Clark, 2009). It can be very 
costly for a mental health centre to have numerous therapy manuals and several clinicians trained 
in the administration of each manual, which would be necessary for disorder-specific CBT 
(Norton & Hope, 2005). 
Secondly, transdiagnostic CBT is practical for its role in enhancing participation in 
therapy.  The group format may increase the availability of treatment (Clark, 2009) and thereby 
reduce waiting list periods (McEvoy et al., 2009).  Time is also saved by not having to find a 
treatment that is specific to the individual’s symptom presentation (Mansell et al., 2009). 
Additionally, Clark (2009) asserts that the broad nature of these protocols may be less ominous 
to clients who are hesitant about participating in therapy. 
Thirdly, a transdiagnostic approach may be considered pragmatic for its ability to 
address comorbidity.  This may be particularly advantageous, since comorbidity can pose 
difficulties regarding treatment response and implementation.  Regarding treatment response, 
Coryell et al. (1988) reported that patients with panic disorder and major depression are less 
likely to recover over a two-year period than those without the comorbid diagnosis.  As such, 
consideration of co-occurring anxiety and mood disorders during the facilitation of treatment is 
warranted.  Despite the significance of comorbidity, randomized controlled trials investigating 
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diagnosis-specific protocols often use participants who have one diagnosis (McManus et al., 
 
2010).  If the empirically supported treatment has not been used with comorbid presentations, 
then the clinician is faced with a difficult task of deciding how to proceed when a client presents 
with comorbidity.  The clinician may use the intervention designed for the primary diagnosis 
with the hope that it also improves other symptoms, or a clinician may use one intervention after 
another to target each diagnosis or one may combine components from various protocols 
(McManus et al., 2010).  While using a diagnosis-specific intervention could simultaneously 
treat an alternate diagnosis, the likelihood of this is uncertain.  Studies have indicated that the 
comorbid diagnosis usually remains after an intervention targeting a primary diagnosis is 
administered (Allen, Ehrenreich, & Barlow, 2005; Tsao et al., 2002).  A further disadvantage is 
that the use of multiple treatments uses more resources (McManus et al., 2010).  It is also 
problematic to combine components from different protocols due to the lack of research 
indicating how to do so.  Moreover, combining treatment interventions has been demonstrated to 
weaken the efficacy of the interventions (McManus et al., 2010).  Evidently, the co-existence of 
various anxiety and mood disorders poses difficulties for treatment implementation when using 
diagnosis-specific empirically supported treatments.  A transdiagnostic approach may alleviate 
some of these difficulties, as the broad treatment protocol is designed to address various 
disorders and residual symptoms. 
 
Further diagnostic issues may be addressed with the transdiagnostic approach.  When 
clients do not meet criteria for a disorder that corresponds to a specific treatment model, such as 
a diagnosis of anxiety disorder not otherwise specified, a transdiagnostic approach offers a way 
to provide evidence based treatment (Mansell et al., 2009).  Since determination of a primary 
anxiety diagnosis is not necessary to for transdiagnostic CBT, this may also enhance treatment 
MECHANISMS OF CHANGE WITHIN GCBT 19  
 
 
availability (Clark & Taylor, 2009).  The deviation away from linking a specific disorder to a 
specific treatment might contribute to shifting the clinical focus onto the individual patient. 
Mansell and colleagues suggest that transdiagnostic treatment may promote the use of an 
idiographic approach, as clinicians would focus on how maintaining processes are operating for 
each individual.  A disorder-specific protocol may be more structured and so the unique 
processes within each individual may be less of a focus (Mansell et al., 2009). 
The transdiagnostic approach to treatment appears to follow the principles of parsimony 
and pragmatism, while posing advantages over single-service treatments such as the greater cost- 
effectiveness, increased therapy participation, and a greater ability to address comorbidity. 
These advantages may also promote the dissemination of empirically supported CBT. 
 
Disadvantages of a transdiagnostic approach. Despite the numerous benefits offered 
by a transdiagnostic approach to treatment implementation, some disadvantages persist. 
McEvoy et al. (2009) caution that group cohesiveness could be hindered due to the 
heterogeneous composition of the group, as clients may be less able to relate to one another and 
to learn from one another.  This could have negative effects on therapy outcomes (McEvoy et al., 
 
2009).  Additionally, treatment that is broad may be less efficacious in reducing anxiety 
symptoms than therapies focusing on a specific, primary disorder (Craske et al., 2007).  Another 
disadvantage is the uncertainty regarding how transdiagnostic a transdiagnostic treatment should 
be (Mansell et al., 2009).  For example, transdiagnostic treatment could be designed for anxiety 
disorders or all Axis I disorders.  Currently, the former approach is utilized.  However, the 
balance between using a treatment that is most practical and that targets common features and 
mechanisms could have unclear boundaries.  Despite these disadvantages, a transdiagnostic 
approach still has clinical utility due to its feasibility, cost-effectiveness, ability to address 
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comorbidity and ability to enhance therapy participation and dissemination of evidence-based 
treatment.  The disadvantages merit careful consideration, as the most efficacious treatments 
should be provided to clients.  Research regarding the efficacy and effectiveness of 
transdiagnostic CBT has been promising thus far, which supports the use of this approach. 
Combining transdiagnostic and disorder-specific approaches.  Rather than comparing 
the efficacy of disorder-specific and transdiagnostic protocols, some researchers have suggested 
a combined use of these formats.  Clark (2009) has proposed using transdiagnostic CBT as a 
relapse prevention program that clients participate in after undergoing individual therapy. 
Alternatively, patients could participate in transdiagnostic CBT initially to prevent the 
occurrence of comorbid symptoms (Dozois, Seeds, & Collins, 2008).  The multiple potential 
uses of a transdiagnostic treatment group reinforce the need for this therapy approach to be 
rigorously evaluated in order to determine how it can be most beneficial for patients. 
Mediators and Moderators of Therapy Outcomes 
Though previous studies have supported the efficacy and effectiveness of heterogeneous 
treatment groups, it is less certain how the symptom reduction occurs.  Gaining a better 
understanding of how a treatment exerts its effects is critical to formulating effective protocols 
and to understanding the nature of disorders.  Kazdin (2007) has asserted that treatment 
mechanisms can begin to be understood by first exploring mediation.  Identifying variables that 
account for the reduction in anxiety and depression symptoms following treatment will provide 
insight as to how a transdiagnostic approach works.  Very few studies have examined mediators 
of symptom change in a diagnostically heterogeneous GCBT.  Accordingly, several authors have 
advocated the need for future studies to examine the mechanisms of change within 
transdiagnostic CBT (Clark, 2009; Mansell et al., 2008; McEvoy et al., 2008).  Dozois et al. 
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(2009) asserted that examination of transdiagnostic CBT may further elucidate the common 
processes among anxiety and mood disorders. 
Cognitive change. Change in cognitive processes is often considered the basis of CBT 
outcomes.  Despite the centrality of cognitive change to CBT, it can also be achieved through 
other therapies (Chambless & Gillis, 1993).  Some theories in the literature attempting to explain 
the role of cognitive change in CBT have suggested that a change in cognitions may act as a 
mechanism of change within the therapy (Bandura, Adams, & Beyer, 1977).  It has also been 
suggested that cognitions, anxiety, and avoidance may interact, causing a change in one to lead 
to a change in another (Chambliss & Gillis, 1993).  However, further research is needed to 
elucidate the relationship between cognitive change and CBT outcomes (Chambliss & Gillis, 
1993). 
 
Studies exploring the role of cognitions in contributing to CBT outcomes have primarily 
focused on specific anxiety disorders.  Cognitive change following CBT has been indicated 
among patients with GAD, social phobia, and panic disorder with or without agoraphobia, and 
the cognitive change has been associated with symptom reduction (Chambless & Gillis, 1993). 
Wells (1995) proposed that maladaptive cognitions such as negative appraisals of worry or 
beliefs about worry uncontrollability can maintain pathological worry. Several models of 
generalized anxiety disorder (GAD) recognize the role of cognitive factors in the maintenance of 
worry (e.g., Dugas, Gagnon, Ladouceur, & Freeston, 1998; Wells, 1995). Worry has also been 
examined as a mechanism of change among individuals with GAD.  Donegan and Dugas (2012) 
found that a change in worry and a change in somatic anxiety are related in both CBT and 
Applied Relaxation (AR).  Since worry can be present among individuals with other anxiety 
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disorders, the relationship between change in worry and outcomes following CBT across the 
anxiety disorders warrants further study. 
Additionally, specific cognitions of dysfunctional attitudes have been investigated as a 
mechanism of change in CBT across various anxiety disorders. Beck and colleagues (Beck, 
1983; Beck, Rush, Shaw, & Emery, 1979) have proposed the cognitive mediation hypothesis, 
suggesting that a causal relationship exists between dysfunctional attitudes and depression and 
anxiety.  However, a study conducted by Burns and Spangler (2001), found that dysfunctional 
attitudes did not mediate CBT outcomes for anxiety.  Though evidence for mediation was not 
found, dysfunctional attitudes and therapy outcomes were correlated (Burns & Spangler, 2001). 
As such, it is evident that a cognitive component relates to CBT outcomes across various anxiety 
disorders, but it does not necessarily account for symptom change.  Despite the theoretical 
emphasis on cognitions as a mechanism of change in CBT, studies have yet to produce consistent 
results on the role of cognitive change. 
Intolerance of uncertainty.  Intolerance of uncertainty (IU) is another cognitive 
component that has been examined as a maintaining factor among anxiety and depressive 
disorders.  Intolerance of uncertainty is a cognitive bias in which ambiguity or an unknown, 
possibly adverse future event is considered to be negative and causes distress for the individual 
(Ladouceur, Talbot, & Dugas, 1997; Koerner & Dugas, 2008).  IU has been demonstrated to be a 
vulnerability factor for worry (Sexton et al., 2003), and to predict social anxiety severity (Boelen 
& Reijntjes, 2009), symptoms of panic disorder and agoraphobia (McEvoy & Mahoney, 2011), 
depressive symptoms (McEvoy & Mahoney, 2011; Miranda, Fontes, & Marroqui’n, 2008), GAD 
and OCD symptoms (Fergus & Wu, 2010). Additionally, IU has been demonstrated to mediate 
the relationship between neuroticism and symptoms of various anxiety disorders and depression, 
MECHANISMS OF CHANGE WITHIN GCBT 23  
 
 
with a particularly strong influence on worry (McEvoy & Mahoney, 2012).  IU appears to be a 
construct that is associated with anxiety and mood disorders. Though associations between IU, 
anxiety and depression have been established, it is unclear how targeting IU in therapy affects 
therapy outcomes for each of the anxiety and mood disorders. Studies examining treatment 
outcomes have indicated that IU is related to symptom improvement following CBT for GAD 
(Dugas & Ladouceur, 2000) and social phobia (Hewitt, Egan, & Rees, 2009) as well as for OCD 
following an exposure and response-prevention program (Overton & Menzies, 2005).  These 
findings indicate promising potential for the role of IU, but there is need to further validate the 
relationship between IU and psychotherapy outcomes across various anxiety and mood disorders. 
McEvoy and Mahoney (2012) have asserted that there is a need for research to compare IU as a 
mediator of symptom change to other mediators in order to clarify whether IU has a unique role 
in contributing to positive outcomes.  Overall, there is a dearth of research examining cognitive 
mediation of CBT outcomes for anxiety disorders and research that has been generated thus far 
has largely focused on symptom change for a particular disorder.  To thoroughly evaluate 
transdiagnostic CBT, the mechanisms within this therapy approach need to be examined. 
Homework compliance.  Engagement in therapy has also been examined as a mediator 
of symptom change in mixed-anxiety CBT groups.  In their study of CBT for a transdiagnostic 
anxiety disorder group, Westra et al. (2007) found that the relationship between expectancy for 
change and post-treatment outcome was mediated by homework completion. Their analyses also 
indicated that the relationship between homework completion and post-treatment outcome was 
mediated by initial cognitive symptom change (Westra, Dozois, & Marcus, 2007).  Therefore, 
homework compliance is related to expectancy for change and early symptom improvement but 
it does not uniquely account for positive outcomes. 
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The relationship between therapy outcomes and homework compliance has been 
analyzed across various psychotherapies and disorders.  Mausbach, Moore, Roesch, Cardenas, 
and Patterson (2010) conducted a meta-analysis of 23 studies conducted since 2000, and they 
found a significant relationship between greater homework compliance and improved 
psychotherapy outcomes for depressive, anxious, and substance use symptoms.  The authors 
suggest that homework compliance relates to positive outcomes as it facilitates the practice of 
skills taught in therapy (Mausbach, 2010).  Greater homework compliance has been related to 
symptom improvement following CT and CBT for patients with major depressive disorder 
(Bryant, Simons, & Thase, 1999; Burns & Nolen-Hoeksema, 1991).  However, some 
contradictory findings have also been produced.  Neimeyer, Kazantzis, Kassler, Baker, and 
Fletcher (2008) analyzed depressive symptoms following CBT and determined that homework 
compliance did not predict symptom change.  Though homework compliance alone was not a 
significant predictor in this study, the combined effects of homework compliance, willingness to 
complete homework, and cognitive skill acquisition predicted depressive symptom change 
(Neimeyer et al., 2008).  These results indicate that the influence of homework compliance may 
be part of a greater construct such as therapy engagement. 
Studies examining the relationship between homework compliance and therapy outcomes 
for anxiety disorders have also produced results that do not support the findings of Mausbach et 
al. (2010).  Homework compliance was not related to improved outcomes following CBT for 
patients with social anxiety (Woody & Adessky, 2003) and panic disorder (Schmidt & 
Woolaway-Bickel, 2000). The lack of consistency regarding the role of homework compliance in 
the literature may be related to the variety of methodologies used, as homework compliance 
ratings may be completed by patients or therapists at various points in the therapy process. 
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Therefore, there is a need to further explore the role of homework compliance in contributing to 
therapy outcomes for anxiety disorders.  As the study of transdiagnostic CBT for anxiety is in its 
infancy, it would be useful to gain an understanding of how engagement in therapy homework 
contributes to symptom change at post-treatment. 
The Present Study 
 
The present study examined patient outcomes following transdiagnostic GCBT for 
anxiety symptoms at St. Joseph’s Care Group in Thunder Bay to determine if this approach is 
effective and to gain a better understanding of how this therapy works. These analyses will 
contribute to the understanding of whether a transdiagnostic approach is effective in treating 
anxiety symptoms and to the understanding of the mechanisms by which CBT exerts its effects. 
This study extends previous literature by elucidating the role of intolerance of uncertainty as a 
transdiagnostic construct and by clarifying the role of cognitions in contributing to outcomes 
following a transdiagnostic CBT protocol. 
Hypotheses 
 
The primary aim of the present study was to evaluate the efficacy of a transdiagnostic 
GCBT protocol. This study also aimed to identify variables that contribute to symptom 
improvement. Specifically, cognitive change and homework compliance were examined as 
mechanisms that influence treatment outcome. 
H1: Participants were expected to experience significant symptom improvement at post- 
treatment on anxiety measures.  As the current literature supports the efficacy of a 
transdiagnostic group CBT for anxiety disorders, anxiety symptoms were predicted to improve at 
post-treatment. 
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H2:  It was hypothesized that participants would experience significant symptom improvement 
at post-treatment on depression measures. Since anxiety and mood disorders may share a 
common underlying construct such as negative affect (Clark & Watson, 1991), treatment that 
affects the underlying construct is expected to influence both anxious and depressive symptoms. 
Furthermore, transdiagnostic CBT for anxiety has been shown to reduce co-occurring mood 
symptoms (Norton et al., 2004).  As such, participants receiving the treatment were expected to 
demonstrate significant reduction in depressive symptoms. 
H3:  It was hypothesized that early cognitive change would predict late symptom change. 
Following the theoretical premise of CBT and evidence of an association between cognitive 
change and treatment outcomes for various anxiety disorders (Chambless & Gillis, 1993), it was 
expected that early cognitive change would be associated with overall symptom change. 
H4: It was hypothesized that overall cognitive change would account for the change in Beck 
Anxiety Inventory (BAI) scores for the treatment group.  In accordance with Kazdin’s (2007) 
recommendation to analyze multiple mediators, three measures of cognitions were examined as 
mediators.  Changes in measures of general anxiety and depression-related cognitions were 
expected to mediate symptom outcomes.  As CBT is based on the premise that cognitive change 
acts as a mechanism in therapy, the measure of general cognitions was expected to have a 
mediating role.  Change in intolerance of uncertainty (IU) is another cognition that was expected 
to mediate the relationship between CBT and symptom change.  The recognition of IU as a 
transdiagnostic construct and the documented correlation between IU and positive outcomes 
across disorders (Dugas & Ladouceur, 2000; Hewitt et al., 2009; Overton & Menzies, 2005) 
suggested that IU could have a causal role in affecting symptom change.  Lastly, change in worry 
was examined as a mediator.  Change in worry has been related to CBT and to a change in 
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anxiety symptoms (Ladouceur et al., 2000).  As such, change in worry symptoms was expected 
to mediate the relationship between CBT and overall anxiety symptom change.  However, 
statistical indication of mediation does not necessarily indicate that the variable is a mediator 
since it is unknown whether the cognitive change precedes the symptom change (Kazdin, 2007). 
H5:  It was hypothesized that homework compliance would moderate the relationship between 
CBT and symptom change.  Completing homework assignments was expected to influence 
symptom change over the course of treatment, as some previous research has shown homework 






This study consisted of participants attending a transdiagnostic anxiety CBT group at St. 
Joseph’s Care Group in Thunder Bay, Ontario.  Clients were referred to the therapy group by an 
intake clinician or therapist if they were experiencing a high level of anxiety symptoms.  The 
data collection period spanned from June 2013 to July 2014 in order to maximize the sample 
size, as an a prior power analysis for multiple regressing using G*Power 3.0.10 (Faul, Erdfelder, 
Lang, & Buchner, 2007) suggested a sample size of N = 50 to detect a large effect size, and a 
sample size of N = 108 to detect a medium effect size.  Throughout this data collection period, 
the group was offered at three times: summer 2013, and winter and spring of 2014.  However, 
there was no complete participation from the summer 2013 group, and a different therapy 
manual was used beginning in fall 2013, so any partial data from the summer 2013 group was 
not included in the present study.  Two therapy groups ran simultaneously during winter 2014, 
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Data was collected from the therapy groups at three time points: pre-, mid-, and post- 
treatment.  The group facilitator introduced the study at end of the first therapy session, and then 
all potential participants were given a package to take home with them that included an 
information letter (Appendices A-C) and self-report questionnaires. A drop-box was left in the 
waiting room for people to discard their package anonymously if they did not want to participate. 
The questionnaire packages also included a ballot for participants to complete and mail 
separately to the researchers if they wished to receive a gift card to thank them for their 
participation. Two pre-addressed stamped envelopes were included in the packages for 
participants to mail both the completed questionnaires and a ballot to the researchers.  Another 
package of self-report questionnaires was given to clients at the end of the fourth therapy session 
and the end of the last session, with participants again being asked to mail their responses and 
ballots back to the researchers. Therefore, data was collected from some clients in the treatment 
group at approximately the beginning, middle, and end of treatment. 
At each assessment time-point, the group facilitator notified participants of the study 
using the scripts presented in Appendix D.  Some of the self-report measures used in the study 
were administered during treatment sessions for separate program evaluation purposes, instead of 
being included in the questionnaire packages.  A self-generated code was used to track 
participants’ responses across time, and to match the measures submitted during sessions to those 
submitted by mail.  This process was explained to clients using the script outlined in Appendix 
D. 
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Data collection from a wait-list control group had been intended, but was not possible 
due to the removal of the wait-list.  Program changes were made at St. Joseph’s Care Group in 
fall 2013, whereby a wait-list no longer existed.  Instead, two therapy groups were facilitated 
simultaneously so that all referred clients could be offered treatment and would not need to wait 
until the following therapy group to receive services. 
Measures 
 
To measure symptomatology, cognitions, and homework compliance, a number of 
instruments were chosen based on their psychometric properties and use in previous research. All 
measures were completed at all three time points, with the exception of the homework measure, 
which was assessed twice.  The packages of self-report measures included the Beck Anxiety 
Inventory (BAI), Beck Depression Inventory-II (BDI-II), Penn State Worry Questionnaire 
(PSWQ), Positive and Negative Affect Schedule (PANAS), Intolerance of Uncertainty Scale 
(IUS-12), the Cognitions Checklist (CCL), and a Homework Compliance measure that was 
completed at mid- and post-treatment.  A demographic questionnaire (Appendix E) was also 
administered to participants at each time-point. 
Beck Anxiety Inventory. The Beck Anxiety Inventory (BAI) was administered to assess 
anxiety symptoms. This is a self-report questionnaire that consists of 21 items measuring anxiety 
symptomatology (Beck & Steer, 1993). The BAI uses a 4-point Likert-type scale where 
participants rate the frequency to which they have experienced each symptom in the past month, 
ranging from a rate of 0 for “Not at all” to 3 for “Severely – it bothered me a lot.” The BAI has 
been factor analyzed into two components of somatic symptoms and cognitive symptoms 
(Borden et al., 1991; Hewitt & Norton, 1993). High internal consistency (Cronbach’s alpha = 
.94) of the BAI has been demonstrated among a sample of outpatients with anxiety disorders 
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(Fydrich, Dowdall, & Chambless, 1992). Among a non-clinical sample of undergraduate 
students, the BAI was demonstrated to have high internal consistency (Cronbach’s alpha = .90), 
a moderate test-retest correlation (.62), and discriminant and convergent validity were supported 
through low and moderate correlations to the Beck Depression Inventory and State Trait Anxiety 
 
Inventory, respectively (Creamer, Foran, & Bell, 1995). On this measure, scores that range from 
 
8-15 reflect mild anxiety, while scores of 16-25 indicate moderate anxiety and scores of 26-63 
indicate severe anxiety (Beck & Steer, 1990). These scores are overall estimates of the 
individual’s anxiety symptom severity level (Beck & Steer, 1990). 
Beck Depression Inventory – II. The BDI-II (Beck, Steer, & Brown, 1996) was 
administered to assess symptoms of depression, which commonly co-occur with symptoms of 
anxiety.  This is a 21-item self-report scale that measures clinical symptoms of depression. 
Participants rate the frequency with which they have experienced each symptom in the last two 
weeks on a 4-point Likert-type scale.  The internal consistency of the BDI-II has been 
demonstrated by high alpha coefficients of .91 (Dozois, Dobson, & Ahnberg, 1998) and .90 
(Osman et al., 1997) among non-clinical samples of young adults and with a high alpha 
coefficient (Cronbach’s alpha = .91) among psychiatric outpatients (Beck, Steer, Ball, & Ranieri, 
1996).  Reliability of the BDI-II has been further supported through a significant test-reset 
correlation of .93 (Beck et al., 1996).  The convergent validity of the BDI-II has been supported 
through positive correlations with the Beck Hopelessness Scale and the Scale for Suicide 
Ideation, while discriminant validity has been indicated by a low correlation with the Hamilton 
Rating Scale for Anxiety (Beck et al., 1996).  Higher scores on the BDI-II indicate a higher 
presence of depressive symptoms (Beck et al., 1996). 
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Positive And Negative Affect Schedule. The 20-item Positive And Negative Affect 
 
Schedule (PANAS; Appendix F) was administered to assess mood states. This scale consists of 
 
10 items measuring Positive Affect, which is the extent to which a person feels energetic and 
alert and there are 10 items measuring Negative Affect, which is the experience of unfavorable 
mood states. Participants rate the extent to which they have experienced positive affect mood 
states such as “inspired” and negative affect mood states such as “distressed” within the past few 
weeks, using a 5 point Likert-type scale ranging from “very slightly or not at all” to “extremely” 
(Watson et al., 1988).  Higher scores on the Positive Affect scale indicate a higher presence of 
positive affect, while higher scores on the Negative Affect scale indicate greater negative affect 
(Watson et al., 1988).  The independence of the positive affect and negative affect subscales is 
supported by the low inter-correlations ranging from -.12 to -.23 (Watson et al., 1988). 
Reliability and validity of the PANAS have also been demonstrated for various time intervals of 
experienced mood states (Watson et al., 1988). 
Intolerance of Uncertainty Scale. The Intolerance of Uncertainty Scale – Short Form 
(IUS-12; Appendix G) was administered to assess participant’s cognitions.  This is a 12-item 
scale that measures reactions to uncertain events (Carleton, Norton, & Asmundson, 2007).  The 
IUS-12 uses a 5 point Likert-type scale ranging from 1 for “not at all characteristic of me” to 5 
for “entirely characteristic of me” and total scores range from 1 to 60.  Higher scores on this 
scale reflect higher levels of intolerance of uncertainty (Buhr & Dugas, 2002).  A study 
analyzing the reliability of the IUS-12 for clinical and non-clinical samples demonstrated 
Cronbach’s alpha coefficients of .87 and .92, respectively (Khawaja, 2010). 
Penn State Worry Questionnaire - The Penn State Worry Questionnaire (PSWQ; 
Meyer, Miller, Metzger, & Borkovec, 1990; Appendix H) was administered to assess worry 
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symptoms.  This is a 16-item questionnaire that uses a 5-point Likert-type scale to assess how 
typical each worry trait is of the participant. Higher total scores on the PSWQ indicate higher 
levels of pathological worry. The PSWQ has been demonstrated to have high internal 
consistency and convergent validity among a clinical anxiety disorders sample (Brown, Antony, 
& Barlow, 1992).  In a sample of undergraduate students, high internal consistency was reported 
 




Cognitions Checklist. The Cognitions Checklist (CCL; Appendix I) is a 26-item 
measure that assesses the frequency of automatic thoughts related to depression and anxiety 
(Beck, Brown, Steer, Eidelson, & Riskind, 1987). The CCL contains an anxious cognition 
subscale (CCL-A), consisting of 12 items and a depressive cognition subscale (CCL-D) with 14 
items. A high score on the CCL-A reflects the presence of cognitions that are oriented towards 
the future and related to uncertainty, which are cognitions that are associated with anxiety 
disorders. On the CCL-D scale, a higher score indicates the presence of cognitions oriented 
towards the past or cognitions regarding a negative view of the future, which are associated with 
depressed mood. Internal consistency has been demonstrated for both the CCL-A and CCL-D 
with alpha coefficients of .90 and .92, respectively (Beck et al., 1987). Convergent and 
discriminant validity has been supported through correlations with the Hamilton Anxiety Scale- 
Revised and the Hamilton Depression Scale Revised. The CCL-A and CCL-D are designed to 
measure cognitions associated with anxiety and depression, respectively. As such, criterion 
validity has been supported by discriminating between patients with DSM-III diagnoses of 
anxiety and depression (Beck et al., 1987). 
Homework Compliance. Participants were asked to indicate how often they completed 
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the therapy homework by selecting one of four options that ranged from “I completed the 
homework every week” to “I never completed the homework” (Appendix J). 
Description of the Transdiagnostic Anxiety Treatment 
 
Clients referred to the mixed-anxiety CBT group attended the group once a week for 2 
hours over an 8-week period. The CBT group therapy was a manualized CBT group program 
facilitated by a psychologist and clinical psychology or social work graduate students. The 
groups were typically composed of 10-13 clients.  Some of the material covered throughout the 
therapy included: psychoeducation, relaxation strategies, discussion of anxiety maintaining 
factors, exposure, challenging unhelpful thoughts, mindfulness, and homework assignments.  A 
more detailed outline of the core components covered in each session is presented in Table 1. 













1 Introductions, review of group rules and confidentiality, discussion of “what is 
anxiety”, introduction to the CBT model of anxiety, abdominal breathing practice, 
introduction to tracking cards, homework assignment 
2 Homework discussion, review of breathing technique, review of anxiety symptoms 
and how they relate to treatment targets, psychoeducation on tension, progressive 
muscle relaxation, homework assignment 
3 Homework review, discussion of behaviours and advantages/disadvantages of 
maintaining anxiety, motivational interviewing, psychoeducation on role exposure, 
exposure hierarchy, homework assignment 
4 Homework review, psychoeducation on beginning exposure tasks, review of exposure 
diary, autogenic relaxation, homework assignment 
5 Homework review, psychoeducation on exposure to internal sensations, discussion of 
anxiety-related thoughts and unhelpful thinking styles, homework assignment 
6 Homework review, introduction to managing unhelpful thoughts, psychoeducation on 
changing and analyzing thoughts, thought diary, relaxation, homework assignment 
7 Homework review, psychoeducation on mindfulness and postponing worry, 
homework assignment 
8 Homework review, discussion of anxiety symptoms and strategies for each symptom, 






Adherence to the therapy manual was assessed with a checklist after each session that 
was completed by the group facilitator.  The checklist (Appendix K) contained the list of 
components to be covered in that session and a 4-point rating scale to assess the order in which 
the components were covered, which ranged from “the session rarely followed the treatment 
protocol” to “the session followed the treatment protocol”.  Overall adherence to the manual was 
high.  Of all the sessions assessed (N = 32), 231 out of the 240 listed components were covered 
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in the session that the manual specifies.  Nine sessions (28.1%) were rated to mostly follow the 
treatment protocol, while 23 sessions (71.9%) were rated as following the treatment protocol. 




All statistical analyses were completed using SPSS 21 for Macintosh.  Descriptive 
statistics were used to depict the sample’s demographic characteristics, symptoms, and cognitive 
scores for each time of measurement.  Paired t-tests were conducted to compare the means on the 
BAI, BDI-II, PANAS-PA, and PANAS-NA across the three assessment time points. 
Three change scores were computed for each of the outcome and cognitive measures by 
subtracting the pre-treatment scores from the mid-treatment scores (“early change”), subtracting 
the mid-treatment scores from the post-treatment scores (“late change”), and subtracting pre- 
treatment scores from post-treatment scores (“overall change”).  The relationships between the 
change scores on cognitive and symptom measures were investigated using Pearson correlations. 
Regression analyses were conducted to examine if early cognitive change predicted late 
symptom change and hierarchical regression was used to determine if cognitive change mediated 
symptom change.  The mediation model consisted of post-treatment BAI scores as the dependent 
variable, pretreatment BAI scores entered in the first step, demographic predictors were entered 
at the second step, and overall change scores on the cognitive measures entered at the third step. 
This model is depicted in Figure 1.  Finally, correlations between homework compliance scores 
and symptom change scores were examined to determine if homework compliance was a 
moderator of anxiety symptoms. 

















Data were collected from four transdiagnostic anxiety treatment groups that ran between 
January 2014 and July 2014 at St. Joseph’s Health Centre.  The sample for this study consisted 
of 15 participants who were attending one of the groups.  A total of six participants completed 
the questionnaires at all three time-points.  The demographic characteristics of the participants 
are outlined in Table 2. 











Participants (N = 15) 
M (SD) Frequency % 
45.07 (10.81) 
Male 3 20.0 
Female 12 80.0 
Ethnicity* 
White/Caucasian/European 14 93.3 
Aboriginal/African-Canadian 3 20.0 
Marital Status 
Married/common-law 7 46.7 
Never married 4 26.7 
Separated 2 13.3 
Divorced 2 13.3 
Income 
Below $20,000 5 33.3 
$20,000 - $40,000 4 26.7 
$40,000 - $60,000 2 13.3 
$60,000 - $80,000 3 20.0 
$100,000 or above 1 6.7 
Employment Status 
Work full-time 3 20.0 
Work part-time 2 13.3 
Retired 1 6.7 
Do not work 9 60.0 
Received Diagnosis 
Yes 11 73.3 
No 2 13.3 
Missing/Unknown 2 13.3 
Type of Diagnosis* 
Anxiety 5 33.3 
PTSD 4 26.7 
Depression 6 40.0 




Learning Disability 1 6.7 
Receiving Another Treatment* 
No 3 20.0 
Yes 12 80.0 
Medication 10 66.7 
Individual Tx 10 66.7 
Group Tx 3 20.0 
Other 3 20.0 
Note.  Tx = Treatment. Individual and group treatment refers to receiving other therapy or 
counselling in individual or group formats, at the same time as the transdiagnostic group 
* non-exclusive. 





The data was screened prior to analysis using IBM SPSS programs.  Following the 
recommendations of Tabachnick and Fidell (2013), the data was checked for accuracy, missing 
values, normality, multicollinearity, and outliers.  All descriptive statistics appeared to be within 
expected ranges. Variable skewness and kurtosis was not significant enough to warrant variable 
transformations. Missing Values Analysis (MVA) was conducted to examine the missing 
patterns among the data, and Little’s Missing Completely At Random test indicated that the data 
was not missing completely at random,   2 (2901) = 12,000,819.983, p < .001.  Most of the 
missing data was due to participant drop-out (drop-out from the study – not necessarily the 
therapy group), and complications matching the mailed measures to the measures completed in 
the therapy room.  Twelve items in the dataset had been left blank or were skipped by 
participants.  Mean imputation was used to replace these 12 missing values.  The Pearson 
product-moment correlations between all of the scale totals (as presented in Table 3) were 
examined for multicollinearity. At Time 2 the IUS-12 and PANAS-NA scores were very highly 
correlated, r = .96, p < .001, while the Time 3 scores on the PANAS-NA and the BAI were also 
high, r = .91, p < .01.  This suggests a high degree of relatedness among these constructs. Lastly, 
the data were searched for outliers. No univariate outliers were detected from an analysis of z 
scores.  Mulivariate outliers were searched for among the variables used in the regression 
analyses, and none were identified with Mahalanobis distance at a criterion of p < .001. 
Differences between individuals who provided complete data and those who did not 
(non-completers) were examined using independent sample t-tests.  Non-completers had 
significantly higher scores on the BDI-II (15 point difference) and CCL (25 point difference) at 
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pre-treatment.  No other significant differences were noted.  In order to maximize the available 
sample size, pair-wise deletion was used for each analysis. 
Table 3 
 
Correlations Between Cognitive and Symptom Measures at Pre-, Mid-, and Post-Treatment 
 
Pre-treatment Mid-treatment Post-treatment 
 































BDI-II .47 .82** .64* .60 .41 .15 .32 .18 .05 
PANAS-PA -.21 -.26 .03 .32 .07 .39 .27 .16 .37 
PANAS-NA .33 .63* -.02 .32 .62** .31 .52 .68* .32 
 
Mid-treatment 
         
BAI -.40 .10 .18 .41 .20 .16 -.06 .05 .18 
BDI-II .69 .60 .17 .83* .83* .70 .81* .67 .61 
PANAS-PA -.14 .12 .30 -.06 .13 .31 -.01 .24 .09 
PANAS-NA .17 .62 .43 .62* .50 <-.01 .39 .36 .40 
 
Post-treatment 
 BAI .10 .54 .24 .64 .35 .36 .42 .46 .65 
 BDI-II .50 .36 .15 .74* .84* .76 .87** .78* .81** 
 PANAS-PA -.39 -.08 .11 -.37 -.24 .07 -.28 -.28 -.45 
 PANAS-NA .02 .50 .25 .55 .56 .50 .47 .65 .74* 
Note.   Correlations were conducted using pair-wise deletion, so the sample size contributing to 
each bivariate correlation differs. 
* p < .05 
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The means and standard deviations of the total score on each scale at pre-, mid-, and post- 
treatment are presented in Table 4.  In terms of pre-treatment distress, participants’ scores fell in 
the “severe” range on both the BAI and BDI-II.  With the exception of the BAI from Time 2 to 
Time 3, and the PANAS-PA from Time 1 to Time 2, the means changed in the expected 
directions over the course of the GCBT.  Cronbach’s alpha ranged from .80 to .97 (see Table 5) 
at each time point, indicating good internal consistency.  However, alpha values for the BAI at 
Time 1 and Time 3, the IUS-12 at Time 3, and the CCL at Time 3, were greater than .95.  This 
may indicate some redundancy among the items (Tavakol & Dennick, 2011) or may be due to 
the small sample size. 
Table 4 
 























  PANAS-NA  33.07  7.66  15  29.72  6.10  11  26.28  7.75  9   






Reliability of the Measures at Each Time Point 
 
Time 1 Cronbach’s 
α 
Time 2 Cronbach’s 
α 
Time 3 Cronbach’s α 
IUS-12 .90 IUS-12 .91 IUS-12 .96 
CCL .92 CCL .95 CCL .97 
PSWQ .83 PSWQ .89 PSWQ .89 
BAI .97 BAI .92 BAI .97 
BDI-II .91 BDI-II .93 BDI-II .95 
PANAS-PA .92 PANAS-PA .93 PANAS-PA .95 
  PANAS-NA   .84   PANAS-NA   .80   PANAS-NA   .82   
 
 
Hypotheses 1 and 2 
 
Paired t-tests were conducted to evaluate whether symptom improvement was significant 
over the course of treatment.  Anxiety symptom improvement was first examined with a paired 
samples t-test that compared whether the means of BAI total scores differed significantly from 
pre-to mid-treatment, mid- to post-treatment, and pre- to post- treatment.  These comparisons 
were not significant, suggesting that anxiety symptoms did not improve significantly among the 
individuals included in the analysis.  Paired t-tests were conducted in the same manner to 
compare the means of the mood outcome variables (BDI-II, PANAS-PA, and PANAS-NA) 
across the different time points, with.  Again, none of the t-tests were significant.  Contrary to 
predictions, the anxiety and mood symptoms did not appear to improve significantly over the 
course of GCBT. 
Hypothesis 3 
 
To examine whether early cognitive change predicts late symptom change, correlations 
among the change scores were first examined. As can be seen in Table 6, the early cognitive 
change scores were not significantly correlated with the late symptom change scores.  However, 
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early cognitive change on the CCL and PSWQ were positively and significantly correlated with 
early change on the BDI-II, while early change on the IUS-12 was significantly correlated with 
early change on the PANAS-NA.  The relationships between overall change on all measures, and 
early and late changes, are outlined in Tables 7 and 8. 
Subsequent regression analyses were conducted where early cognitive change scores (on 
the IUS-12, CCL, and PSWQ) were entered simultaneously as the predictors, and the late change 
in a single symptom outcome measure was the dependent variable.  Thus, late change scores for 
the BAI, BDI-II, PANAS-PA, and PANAS-NA were each entered individually as a dependent 
variable in four separate regression analysis.  None of these models were significant. 
Post-hoc analysis examined whether scores on the cognitive measures changed across the 
course of treatment.  Paired samples t-tests were conducted for each cognitive measure to 
examine the change in mean scores from pre- to mid-treatment, mid- to post-treatment, and pre- 
to post-treatment.  For the IUS-12, changes from pre- to mid-treatment and pre- to post-treatment 
were not significant, but the change from mid- to post-treatment was significant, t(8) = 2.186, p 
= .036.  Paired t-tests were conducted in the same manner for the PSWQ, CCL, and the two 
subscales of the CCL (CCL-A and CCL-D), but none of the changes were significant.  Aside 
from the significant change on the IUS-12 from mid- to post-treatment, the extent of cognitive 
change at other time points and on the other cognitive measures, was not greater than what 
would occur by chance.  This general lack of cognitive change may explain why cognitive 
change was not found to predict symptom change. 
 




Pearson Product-Moment Correlation Coefficients Among Early and Late Change Scores 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14  
1. IUS-12 – a                
 
2. CCL – a 
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Note. a = Early change; b = Late change 
* p < .05 
** p < .01 





























































1. IUS-12 – a 
 






















































































































































































































Note. a = Early change; b = Late change; c = Overall change 
* p < .05 
** p < .01 





Pearson Product-Moment Correlations Between Overall Change Scores 
 
 1 2 3 4 5 6 7 





























































* p < .05 




A hierarchical regression was conducted to examine whether cognitive change mediates 
change in anxiety scores over the course of GCBT.  In other words, overall cognitive change was 
examined as a mediator of the relationship between pre- and post-treatment anxiety scores, as 
measured by the BAI.  In the hierarchical regression model, post-treatment anxiety score on the 
BAI was entered as the dependent variable, while pre-treatment BAI scores were entered at Step 
1 and demographic variables were entered at Step 2 in order to control for these variables.  Given 
the small sample size, only the demographic variables of Age and Sex were entered at Step 2 in 
order to reduce the total number of predictors.  The overall change scores on the IUS-12, CCL, 
and PSWQ were entered in the third and final step of the regression model.  In the first step of 
the hierarchal regression, R was significantly different from zero, F(1, 7) = 6.73, p < .05. The 
adjusted R
2 
value in the third step suggested that all of the variables in the model, together, 
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account for 78% of the variability in post-treatment BAI scores. However, the addition of the 
demographic and cognitive variables did not significantly improve the fit of the model. 
Therefore, the overall change on the cognitive variables was not found to mediate change in 
anxiety symptoms over the course of GCBT. 
Hypothesis 5 
 
Pearson correlations were computed between homework compliance and overall change 
scores on the outcome measures (BAI, BDI-II, PANAS-PA, PANAS-NA) in order to investigate 
whether homework moderates symptom change. Correlations could not be conducted for 
homework ratings given at mid-treatment, due to the lack of variability among the data on this 
variable.  A rating of 3 was given on all of the homework ratings at mid-treatment that could be 
paired with the outcome change variables.  As demonstrated in Table 9, homework completion 




Pearson Correlations between Overall Change Scores on the 
 
Outcome Measures and Homework Compliance at Post-Treatment 
 
Homework Compliance 
















* p < .05 
** p < .01 





The present study sought to evaluate the outcomes of transdiagnostic GCBT, whereby 
participants with heterogeneous anxiety presentations and various comorbidities were treated 
with a single, unified manual.  The study also aimed to gain an understanding of how this 
transdiagnostic treatment format exerts its effects.  More specifically, the two objectives of the 
study were: (1) to assess whether anxiety and mood symptoms improved among participants 
enrolled in the therapy, and (2) to examine potential mediating and moderating variables that 
may contribute to how therapy improves symptoms for clients.  Evaluating the effectiveness of 
this treatment was expected to contribute to the current understanding of the utility of 
transdiagnostic therapy for anxiety, and to uniquely contribute to the literature by examining 
processes of change within transdiagnostic CBT.  As this treatment format may offer advantages 
over other approaches due to its feasibility, demonstrating the efficacy and effectiveness of the 
treatment is particularly important. 
Efficacy of Transdiagnostic GCBT 
 
The hypotheses predicting that anxiety and mood symptoms would improve significantly 
following completion of the therapy group were not supported.  Though the means on each 
outcome measure decreased from pre- to post-treatment, this change was not found to be 
statistically significant.  This finding diverges from the majority of transdiagnostic CBT efficacy 
research that has been produced to date (e.g., Ellard et al., 2010; Erickson, 2003; Garcia, 2004; 
Hooke & Page, 2002; Manning et al., 1994; McEvoy & Nathan, 2007; Norton, 2008; Norton & 
Hope, 2005; van Ingen & Novicki, 2009), although Norton and Hope (2005) did not find 
significant symptom improvement on the self-report measures in their transdiagnostic GCBT 
effectiveness study. 
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The insignificant symptom change found in this study may have been obtained for 
several reasons.  First and foremost, the very small sample sizes (n ranged from 6 to 11) utilized 
in the in the paired samples t-tests may have impacted the results since several participants did 
not complete the questionnaires at all three time points.  These analyses were underpowered for 
the detection of even a large effect size (as determined through G*Power) and this analysis was 
quite likely subject to a Type II error. 
Secondly, the study participants reported greater symptom severity compared to previous 
research.  Some of the people who participated could have had more treatment-resistant 
presentations than what is typically observed.  In examination of pre-treatment symptom 
severity, the pre-treatment means on the BAI fell in between the moderate and severe symptom 
ranges, and the pre-treatment means on the BDI-II fell within the lower end of the severe 
symptom range.  At post-treatment, both of the means on these measures were in the moderate 
symptom range.  Other transdiagnostic treatment studies using these outcome measures reported 
less severe pre- and post-treatment means.  Ellard et al. (2010) reported initial BAI means in the 
moderate range that reduced to mild symptomatology, and BDI-II scores that reduced over 
treatment, but were in the mild symptom range at both time points.  Similarly, McEvoy and 
Nathan (2007) reported pre-treatment means on both the BAI and BDI in the moderate range that 
reduced to the mild symptom range at post-treatment.  Thus, this sample may differ from that of 
other transdiagnostic studies in terms of symptom severity. 
Relationships Between Cognitive Change and Symptom Change 
 
Though changing cognitions forms the basis of CBT, the present study did not find 
support for cognitive mediation of the change in symptoms from pre- to post-treatment. 
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Cognitive change from pre- to mid-treatment was expected to correlate with change on the 
outcome measures from mid- to post-treatment, and early cognitive change was expected to 
predict late change in anxiety symptoms.  The lack of support for these hypotheses may have 
occurred for a number of reasons, including the low statistical power again.  Additionally, an 
extremely high Cook’s value was obtained in the standard regression analysis that examined the 
predictive role of the cognitive variables.  Almost all variables had Cook’s values that were too 
high, suggesting that the data points had too large of an impact on the regression analyses 
(Stevens, 1984).  Furthermore, scatterplots of residuals from the standard regression analysis 
suggested that the relationships between early cognitive change scores and late cognitive change 
scores had low linearity.  The assumptions of a linear model may have therefore been violated. 
While the aforementioned factors may have influenced the analyses, another prominent 
factor that was likely paramount to the lack of support for these hypotheses, is the lack of 
cognitive change that occurred.  Post-hoc analyses indicated that, with the exception of change in 
IU from mid- to post-treatment, cognitive change at all other time-points and with the other 
cognitive measures was not statistically significant.  Thus, cognitive change generally did not 
occur in the present study.  The lack of cognitive change resulted in subsequent analyses not 
supporting the hypothesis that early cognitive change predicts late symptom change. 
Change in cognitions may have been statistically insignificant in the present study, due to 
characteristics of the treatment, participants, or measures.  As the manual used in this study was 
not an exact replica of the transdiagnostic manuals that have been evaluated in published efficacy 
and effectiveness studies to date, the delivery of treatment components in this study could have 
differed.  The core components that have generally been included in other transdiagnostic 
manuals (psycho-education, relaxation, exposure, and thought restructuring), were also included 
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in the therapy analyzed in this study, although, the manner in which these components were 
delivered could have differed.  Also, Norton and Philipp (2008) found in their meta-analysis of 
transdiagnostic studies that treatments including relaxation produced smaller effect sizes than 
treatments without relaxation.  They suggested that this may have been due to how maladaptive 
core beliefs are not addressed with relaxation (Norton & Philipp, 2008).  As the present therapy 
included a relaxation component, perhaps the treatment was less able to target maladaptive 
cognitions. 
It is also possible that the assessment time points in this study may not have been 
frequent enough to adequately capture the sequence of change for cognitive and outcome 
variables.  Kazdin (2007) noted that a pre-, mid-, post-treatment measurement design may give 
the false impression that potential mediators and outcomes changed at the same time, or may not 
be sensitive enough to capture when change occurs.  The timing of particular therapy teachings 
may also impact when cognitive change occurs.  In this study, acknowledging anxiety-related 
thoughts and unhelpful thinking is discussed in session 5, while challenging thoughts is covered 
in session 6, so one may speculate that greater cognitive change would occur after these sessions. 
In the current design, this type of change pattern may be “washed out” due to the time between 
the mid- and post-treatment assessments.  However, it may also be possible that cognitive change 
occurs continuously throughout treatment, since CBT components such as psychoeducation and 
exposure could alter one’s perceptions of their anxiety and situations or stimuli. 
Patient symptom severity may have also contributed to the lack of cognitive change. The 
pre-treatment mean on the IUS-12 in this study was higher than means obtained among patients 
with anxiety disorders in a study by Carleton et al. (2012), which ranged from 37.01 (SD 
= 12.45) to 41.65 (SD = 10.23).  However, the sample of patients with Major Depressive 
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Disorder in Carleton and colleagues’ study had a higher mean score (M = 43.04, SD = 9.20), than 
participants in the present study.  Also, the pre-treatment PSWQ mean in this study was 
indicative of high worry.  There is some evidence of an initially high severity on these cognitive 
measures, which could have impacted outcomes.  Greater symptom severity could also be 
reflective of more salient dysfunctional core beliefs.  People who hold more dysfunctional 
beliefs, or more deeply ingrained dysfunctional beliefs, may show a reduced treatment response. 
Pedrelli, Feldman, Vorono, Fava, and Peterson (2008) reported that patients with high stress and 
high dysfunctional attitudes at pre-treatment demonstrated less symptom change at post- 
treatment than patients without high pre-treatment scores on these variables.  Both symptom and 
core belief severity among the participants in this study could contribute to the lack of cognitive 
change.  With such a small sample size, the analyses would be impacted if even a few 
participants had higher severity. 
The nature of the cognitive measures employed in this study may have further 
contributed to the lack of cognitive change.  To our knowledge, the IUS-12 and the CCL have 
not been used previously in published research examining transdiagnostic treatment for anxiety, 
and the PSWQ has been used in one heterogeneous anxiety treatment (Westra et al., 2007), 
though it was only analyzed among patients with GAD.  Since these measures have not been 
previously used to examine cognitive change in transdiagnostic GCBT for anxiety, it is possible 
that they are not as relevant for this type of treatment. 
Even if cognitions had changed significantly in the present study, there remains the 
possibility that cognitions do not mediate symptom outcomes in transdiagnostic treatment. 
Studies evaluating mediators of change in therapy have not consistently demonstrated cognitive 
mediation (e.g., Burns and Spangler, 2001), although the cognitive-mediation hypothesis 
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proposed by Beck and colleagues (1979) has been supported in GCBT contexts examining 
depressive symptoms as the outcome variables (Dwyer, Hornsey, Smith, Oei, & Dingle, 2011; 
Kwon & Oei, 2003; Marquez-Gonzalez, Losada, Izal, Perez-Rojo, & Montorio, 2007; van 
Aalderen et al., 2012).  As cognitive mediation has rarely been studied within a transdiagnostic 
treatment context, the potential for cognitions to cause symptom change in this therapy is not 
well understood.  Other relationships between cognitive and symptom change are also possible. 
For example, Kwon and Oei (2003) suggested that a bi-directional relationship between 
cognitions and symptoms could exist.  This would suggest that a change in cognitions 
contributes to a change in symptoms, while a change in symptoms also contributes to a change in 
cognitions. 
Alternatively, there may be other variables in this unique type of treatment that also 
contribute to symptom change.  Process variables such as group cohesion or expectancy to 
change could impact the extent to which patients engage in the treatment and receive its full 
effects.  Behavioural change could also potentially relate to symptom change in this type of 
therapy.  Erickson (2003) found that behavioural avoidance improved throughout the course of 
transdiagnostic GCBT for anxiety.  The relationships between group process variables, 
expectancies, behavioural change, and symptom outcomes are in need of further investigation. 
The study also sought to explore IU as a transdiagnostic concept.  Though early change on 
the IUS-12 had low correlations with late change on most outcome variables, it was highly 
correlated with early change on the BAI and the PANAS-NA, and moderately correlated with the 
total change in these variables.  This lends some support for the relevance of IU with a 
heterogeneous anxiety group.  However, in consideration of the lack of statistically significant 
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changes in cognitions, the utility of the cognitive measures in a transdiagnostic context needs to 
be further explored. 
The Role of Homework Compliance 
 
Contrary to prediction, homework compliance assessed after the last session did not 
mediate outcomes in this study.  This finding is likely due to the small sample size obtained, but 
may also be attributable to the way in which homework was assessed.  As only one item 
evaluating the frequency of homework completion was used, this may not adequately capture the 
active ingredient by which homework could potentially influence outcomes.  There may be other 
aspects of homework besides the frequency of completion that could enhance skill acquisition or 
understanding of CBT.  To address this possibility, some studies (e.g., Cammin-Nowak et al., 
2013) have differentiated homework quantity and quality, since a person who is fully engaged in 
the homework activity and uses the activity to relate skills or concepts to their everyday lives, 
may receive greater benefits from this practice than a person who quickly jots down information 
right before a review of the week’s homework commences.  Teasing apart and assessing the 
extent to which a client generalizes the skills and principles practiced through homework to their 
everyday lives, has been suggested as an avenue for future research (Kazantis, Whittington, & 
Dattilio, 2010).  Perhaps the literature has produced inconsistent results concerning the 
relationship between homework and outcomes, because of other constructs related to homework 
completion, such as generalization, that may impact outcomes.  As Kazdin (2007) proclaimed, 
studying moderation of change is important, since it may identify areas that warrant further study 
for their potential to lead to an understanding of a mechanism. 
Another potential reason for the lack of support for homework as a moderator of 
treatment outcomes in this study is the influence of social desirability.  Participants may have 
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endorsed frequent homework completion in order to present themselves in a more favourable 
light.  Therapist-rated homework completion measures that assess both quantity and quality of 
homework may be a useful measurement approach for future studies investigating moderation. 
Limitations 
There are several limitations to the present study that must be acknowledged.  As 
previously stated, the low sample size resulted in the underpowering of all analyses. 
Additionally, the small sample size reduces the representativeness of the sample and the ability 
to generalize any findings. The methods of the present study, such as the lack of a control group 
and lack of randomization constitute other important limitations.  These limitations could not be 
addressed due to structural barriers, as the Mental Health Outpatient Program eliminated the 
wait-list that had been intended to form the control group. 
 
Several other aspects of the study design had been implemented at the requests of the 
Research Ethics Boards (REBs).  Participants were not able to complete the questionnaires in the 
therapy room before or after sessions, or in another room, in order to protect participants’ 
privacy.  Thus, the questionnaires could only be completed by mail.  The mailing format posed 
several limitations; for example, the exact timing of questionnaire completion could not be 
determined.  Some participants may have taken the questionnaire home and completed it 
immediately, while some may have completed them a few days after receiving the package. 
Also, outcome measures and cognitive measures may not have always been completed on the 
same day since some measures were administered during the group sessions for separate 
program evaluation purposes.  With the mailing format, participants were also unable to ask for 
clarification of words or items they did not understand. 
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Other changes made to the study design at the request of REBs included the use of self- 
generated codes to match participants’ questionnaires across time, and the introduction of the 
study after the first therapy session as opposed to before it.  Inconsistencies in the self-generated 
codes sometimes precluded mailed measures from being matched to the program evaluation 
measures at the same assessment time-point, thus resulting in the loss of data.  Introducing the 
study after participants received a first session of therapy limited the ability of the initial 
assessment to reflect true baseline functioning.  Concerns were also posed by the REB about the 
appropriateness of anonymous self-report questionnaires with clinical content, with particular 
concern surrounding the suicide ideation item.  These concerns were addressed through 
discussion, deliberation, and revision, which simultaneously extended the review process.  The 
total time available for data collection was greatly reduced by this review process. 
Consequently, data could not be collected from the winter and spring groups in 2013. 
 
Though the inclusion of a treatment fidelity measure and the measurement of symptoms 
at pre-, mid-, and post-treatment, are methodological strengths of study, there are limitations 
within these approaches.  The utilized clinician-reported treatment fidelity measures could be 
subject to bias as the group facilitator, rather than an observer, completed it.  Videotaping or 
recording sessions so they can be rated for manual adherence by an observer, is one way of 
enhancing the reliability of treatment fidelity measures. 
In terms of the cognitive and symptom measurement time points, assessing all variables 
at every session would have provided a more thorough depiction of the pattern of change for 
each individual.  Moreover, assessment at every session would allow change in cognitions and 
outcomes to be aligned with the specific components covered in the therapy group. 
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As mentioned within the context of the homework compliance measure, self-report 
questionnaires pose limitations such as social desirability.  While clinician-administered 
diagnostic interviews administered at pre- and post- treatment are more reliable methods for 
assessing response to treatment, such an approach may not be relevant for all transdiagnostic 
research.  For example, participants in the present study have not necessarily been given a formal 
diagnosis, so symptom measurement appears to be the most appropriate way of evaluating 
response. 
Uncertainty regarding some patient characteristics is another noteworthy limitation. 
Though the demographic questionnaire asked respondents to list their diagnoses if they have 
been diagnosed, some of the given information was not specific. Respondents may list “anxiety” 
or “depression” which does not differentiate between types of anxiety and mood disorders. 
Medication use, particularly the inability to ensure medication dose was held stable during 
therapy, in another limitation.  As other transdiagnostic studies have included participants taking 
medication (e.g., Ellard et al., 2010; Norton, Hayes, and Hope, 2004; van Ingen & Novicki, 
2009) and still found significant changes, it is more so the inability to know whether medication 
changed during therapy, that is a limitation in this study.  Conclusions regarding therapy 




Many avenues for future transdiagnostic research have been identified due to the 
limitations preventing the present study from accurately evaluating the outlined hypotheses.  As 
transdiagnostic research is relatively new, there is still a pressing need for studies to evaluate the 
efficacy of this therapy format in terms of change on primary and secondary symptoms. 
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Moreover, the mechanisms by which this therapy creates symptom change is still not well 
understood.  In order to advance the current body of research, randomized, controlled studies are 
needed.  Effectiveness studies including participants taking medication is also advantageous 
since it is important to understand how a transdiagnostic approach works in typical clinical 
settings. 
Additional research is also needed to better understand how patient characteristics may 
relate to treatment outcomes.  As this study did not find significant symptom changes over the 
course of treatment, and the initial means of the symptom measures were slightly higher than 
those reported in two of the other transdiagnostic effectiveness studies utilizing the same 
measures, the relationship between symptom severity and outcomes should be further 
investigated within a transdiagnostic treatment context.  The relationship between 
transdiagnostic treatment outcomes and diagnoses also needs to be elucidated, since Erickson et 
al. (2007) found a better response among participants with panic disorder. 
The active mechanisms within transdiagnostic GCBT also needs to be explored further. 
Understanding what it is about the treatment that leads to improved outcomes, could then allow 
the key mechanisms to be targeted in order to enhance treatment response.  Evaluating mediators 
and moderators of treatment outcomes is viewed as an initial step to identifying mechanisms of 
change (Kazdin, 2007).  The present study lays the groundwork for future studies to expand upon 
and enhance with the utilization of larger samples, in order to understand the sequence of change 
in potential mediators and outcomes.  Using a study design that allows for the temporal sequence 
of change to be addressed is crucial to identifying a true mediator of change.  Studies assessing 
change at every session would provide considerable contributions to the understanding of change 
during transdiagnostic GCBT. 
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Lastly, further investigation of proposed transdiagnostic concepts such as negative affect, 
could enhance the understanding of how different disorders and comorbidities can be addressed 
with a unified treatment protocol.  As the Tripartite theory suggests that negative affect is the 
common underlying construct of anxiety and mood disorders, research exploring how this 
construct changes over the course of transdiagnostic CBT is warranted. 
Conclusion 
 
The present study was unable to provide support for the efficacy of transdiagnostic 
GCBT or the mediating role of cognitions, due to several limitations.  However, relationships 
between changes in cognitions and changes in symptoms were identified.  This study provides a 
framework for future studies to expand upon, as important areas were examined.  Specifically, 
this study highlights the need for mechanisms of change within transdiagnostic GCBT to be 
further researched.  Moreover, the use of a pre-, mid-, post-treatment assessment design allows 
for a greater understanding of the sequence of change, compared to the common pre- and post- 
designs that have been employed in most transdiagnostic studies to date.  Transdiagnostic GCBT 
for anxiety is a feasible and cost-effective approach that may enhance the dissemination of 
treatment.  The substantial advantages offered by this type of therapy format due to its 
practicality, heightens the need for its efficacy to be evaluated and for its mechanisms to be 
understood. 
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Study 1 sought to evaluate the effectiveness of a transdiagnostic group CBT protocol and 
to identify variables that contribute to symptom improvement.  However, due to requests made 
by the hospital REB that impacted the study design and participant recruitment, as well as due to 
the difficulties associated with clinical data collection, the feasibility of Study 1 was significantly 
impacted.  Thus, Study 2 sought to examine the study design and methodology used by 
published studies examining mediation in the context of GCBT.  A systematic review of recent 
published literature was conducted to determine the quality of the methodologies used and to 
summarize the research findings in this area. 
As this systematic review draws heavily on Kazdin (2007)’s paper describing mediation, 
his key concepts and definitions will first be reviewed. The criteria required to establish 
mediation are described next, followed by a summary of study design considerations and 
commonly used statistical approaches. 
Key Concepts and Definitions 
 
Elucidating exactly how treatment leads to improved outcomes may enhance the efficacy 
and effectiveness of a given psychotherapy.  If the specific processes by which cognitive 
behavioural therapy exerts its effects are identified, then these processes could potentially be 
capitalized on in order to maximize the benefits of the therapy.  Kazdin (2007) stated that there is 
ample theoretical information regarding why therapy works, but little empirical evidence exists 
to support the theories.  Studies that do seek to understand how therapy works often focus on 
mediation. 
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Kazdin (2007) asserted that there is a key distinction between mediators and mechanisms 
of change in psychotherapy.  A mediator is “an intervening variable that may account 
(statistically) for the relationship between the independent and dependent variable” (Kazdin, 
2007, p. 3).  With regards to Cognitive Behavioural Therapy (CBT), the theoretical basis of a 
mediator suggests that CBT would lead to a change in the mediator variable, which then leads to 
a change in the outcome (Johansson & Hoglend, 2007). While statistical mediation does suggest 
an important relationship between variables, it does not necessarily explain how change occurred 
during therapy. Comparatively, a mechanism is a variable or process that explains how or why 
the change occurred (Kazdin, 2007).  A mechanism extends the statistical mediation relationship, 
as a true mechanism is determined by multiple studies providing empirical and theoretical 
support for the mediating role of the variable.  Additionally, specific methodological 
characteristics must be present to test and demonstrate a mechanism of therapy (Kazdin, 2007). 
Predictors and moderators are other constructs that are commonly evaluated in 
psychotherapy research.  It is important to note how variables that act as predictors or moderators 
differ from that of a mediator.  A predictor is a variable at pre-treatment that provides 
information about outcomes, but it does not interact with the treatment (Johansson & Hoglend, 
 
2007).  A moderator is also a pre-treatment variable, but it interacts with the treatment by 
influencing the direction or magnitude of the effect of therapy on outcomes (Kazdin, 2007). 
Moderators differ from mediators, since mediators change due to the treatment and they are 
indicated as a cause of the outcome (Johansson & Hoglend, 2007).  Though predictors and 
moderators also provide valuable information, mediators are often the focus of studies due to 
their potential to demonstrate causal relationships. 
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Criteria for Establishing Mediators/Mechanisms 
 
In order to determine that a particular variable acts as a mediator or a mechanism of 
change, specific criteria need to be met.  Temporal antecedence of the mediator is a critical 
component of mediation that is highlighted by several authors (e.g., Johansson & Hoglend, 2007; 
Kazdin & Nock, 2003; Kazdin, 2007; Kraemer, Wilson, Fairburn, & Agras, 2002).  This entails 
that the change in the mediator precedes the change in the outcome.  As logically expected, a 
cause would need to occur before an outcome in order to truly be a cause.  Kazdin (2007) 
outlined 7 criteria for mediation, which include: 1) strong association (the therapy must be 
associated with the proposed mediator and the proposed mediator must be associated with the 
outcome variable), 2) specificity (demonstrating that other variables are not mediators), 3) 
consistency (replication of mediating role of the variable), 4) experimental manipulation, 5) 
temporal antecedence of the mediator, 6) gradient (more of the mediator leads to greater 
improvement in outcomes, and 7) plausibility (the way the variable intervenes and affects 
outcomes is plausible and fits with existing theory and scientific knowledge).  Several of these 
criteria must be met in order to assert that a variable is a true mediator in therapy (Kazdin, 2007). 
Accordingly, multiple studies are likely needed to form the strong research background and 
theoretical foundation that is necessary to empirically test mediation.  The particular 
methodologies employed in studies evaluating mediators/mechanisms of therapy also warrants 
consideration, as some research designs may be better able to test these processes. 
Evaluating Mediators and Mechanisms 
 
Study design considerations.  The specificity criterion could be addressed by measuring 
multiple mediators in a single study.  Empirical support generated for the mediating role of a 
variable is strengthened when other variables have also been evaluated, but shown to not act as 
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mediators (Kazdin, 2007).  In order to address the timeline criterion for identifying a mediator, it 
has been suggested that both the mediator variable and the outcome variable be evaluated at 
multiple points throughout the therapy (Johansson & Hoglend; Kazdin, 2007).  Measuring the 
change in each variable at every session would be ideal, as this would provide a detailed account 
of the pattern and timeline of change for each variable.  Kazdin (2007) asserted that the failure to 
establish a timeline regarding change in the mediator and change in the outcome is a common 
limitation of randomized controlled trials. 
Statistical methods for determining mediation.  Establishing statistical mediation is a 
first step in determining a mechanism of change in psychotherapy (Kazdin, 2007).  Several 
methods have been proposed for evaluating whether a variable plays an intervening role in the 
relationship between other variables.  A review by MacKinnon and colleagues (2002) classified 
the methods of measuring mediation into the three categories of causal steps approaches, 
product-of-coefficients tests, and difference-in-coefficients tests, while more contemporary 
approaches also include structural equation modeling (SEM) and bootstrapping. 
Causal steps approaches.  The Baron and Kenny (1986) causal steps method is 
frequently cited as the most commonly used approach to evaluating mediation (e.g., Hayes, 
2009; MacKinnon, Lockwood, Hoffman, West, and Sheets, 2002). Baron and Kenny presented a 
path diagram indicating that a variable acts as a mediator if the following criteria are met: 1) 
variations in the independent variable (IV) account for changes in the proposed mediator, 2) 
variations in the proposed mediator account for variations in the dependent variable (DV), and 3) 
the relationship between the IV and DV is no longer significant once the paths between the IV 
and mediator and the mediator and DV are accounted for.   If the relationship between the IV and 
DV reduces to zero once the mediating variable is accounted for, then this would indicate 
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complete mediation.  Complete mediation is not very likely in social science analyses, as there 
are often multiple factors that impact mediation, so one variable does not often fully explain the 
relationship between two other variables (Baron & Kenny, 1986).  Thus, partial mediation is 
more common.  Partial mediation is when the IV-DV relationship reduces significantly once the 
mediator is controlled for, but this relationship does not completely extinguish (Baron & Kenny, 
1986). 
 
In addition to the Baron and Kenny (1986) method, there are other variants of the causal 
steps approach that follow a similar underlying logic.  In these approaches, the relationship 
between the IV and DV is referred to as the ‘total effect’, which is comprised of the influence of 
the mediator (i.e., the ‘indirect effect’) and the remaining IV-DV relationship after the mediating 
variable has been controlled (i.e., the ‘direct effect’; Tabachnick & Fidell, 2013). To statistically 
evaluate the Baron and Kenny (1886) mediation model, regression analyses are commonly 
conducted to determine whether the three aforementioned paths of mediation are supported. 
Thus, separate analyses are often conducted for each proposed pathway, and the logic of the 
diagram then allows the researchers to conclude whether or not mediation has been 
demonstrated. 
Product-of-coefficients tests.  In contrast to the Baron and Kenny approach, which infers 
a variable’s causal role, there are other approaches to evaluating mediation that consist of 
measuring the indirect effect.  The indirect effect is conceptualized as the product of the path 
from the IV to the mediator and the path from the mediator to the DV, and so it is commonly 
represented by the term, ab (Preacher & Hayes, 2004). The product-of-coefficients tests analyze 
whether the indirect effect is significant, by dividing the indirect effect (ab) by the standard 
error, and then comparing this statistic to a normal distribution (Hayes, 2009; MacKinnon et al., 
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2002).  There are also specific variants of the product of coefficient tests, with the Sobel test 
(Sobel, 1982, 1986) being one of the most commonly used tests in this group.  The Sobel test is 
sometimes used in addition to the Baron and Kenny method, though Hayes (2009) asserts that 
there is little added benefit to combining these approaches, since it is not necessary to establish 
mediation with the causal steps before statistically evaluating the indirect effect.  The Sobel test, 
along with other tests that divide the intervening effect by the standard error and then compare to 
a normal distribution, may be inappropriate when mediation effects are not normally distributed 
(Hayes, 2009). 
As mediation effects are not often normally distributed, some authors have recommended 
using approaches to measure mediation that do not assume a normal distribution of the data. 
Specifically, Hayes (2009) and Zhao, Lynch, and Chen (2010) have recommended using the 
bootstrapping approach.  The bootstrapping approach uses a repeated resampling process to 
create an empirical representation of the distribution of the indirect effects (Hayes, 2009). 
Difference-in-coefficients tests.  Difference-in-coefficients tests are another method for 
evaluating the intervening effect of a variable.  These approaches compare pairs of correlation 
coefficients to examine the IV-DV relationship before and after controlling for the mediator 
(MacKinnon et al., 2002).  Some limitations of the difference in coefficients tests are that some 
are nondirectional, and that these tests do not easily generalize to multiple mediator models 
(Cheung & Lau, 2008; MacKinnon et al., 2002). 
Structural Equation Modeling.  A more contemporary method of evaluating mediating is 
through Structural Equation Modeling (SEM). SEM consists of forming a hypothesized model 
of the relationships between IVs and DVs, as well as the potential mediating pathways.  The 
proposed model is then compared to the data to examine how well the model fits the data.  The 
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indirect effect is evaluated through a product-multiplication approach (ab; Tabachnick & Fidell, 
 
2013).  SEM has some benefits over hierarchical regression approaches due to its ability to 
analyze latent variables with more than one indicator, to control for some measurement errors, to 
outline all relevant pathways and to reflect a more complicated model where multiple variables 
can be assessed simultaneously (Cheung & Lau, 2008). 
Comparison of the statistical tests in simulation studies.  As there are various methods 
 
of evaluating mediation, some studies have been conducted to compare the statistics produced by 
these approaches.  MacKinnon et al.’s (2002) comparison of methods for evaluating intervening 
variables concluded that the causal steps approach may inaccurately estimate Type I error rates 
and have low power, unless there is a large sample size or large effect size.  The difference-in- 
coefficients methods demonstrated higher power than the causal steps approaches, but Type 1 
error rates were still inaccurate.  The product-of-coefficients methods also had higher power than 
the causal steps approaches, but they too had inaccurate Type 1 error rates (MacKinnon et al., 
2002).  This study was later extended by Cheung and Lau (2008), who examined mediation 
effects in SEM as well as the confidence intervals produced by eight different statistical 
methods.  They concluded from their analyses that hierarchical regression may result in 
underestimation of mediator effects due to measurement errors, while SEM is able to control for 
some of the measurement errors.  Additionally, the bootstrapping method was found to produce 
more accurate confidence intervals than the four other analyzed methods that assume a normal 
distribution of the data (Cheung & Lau, 2008). 
Overall, it appears as though contemporary approaches of measuring indirect effects, 
particularly through the use of SEM and the use of bootstrapping to adjust for skewed 
distributions, are effective ways to measure mediation that also address some of the limitations 
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of the earlier approaches. The most effective method for evaluating a mediator will vary 
depending on factors such as sample size, distribution of the data, and whether multiple 
mediators are being examined. 
Though the type of statistical analysis is important when interpreting results, it is also 
critical to consider these results in combination with the study design.  A variable cannot be 
supported as a cause of the outcomes if both statistical mediation and the key criteria outlined by 
Kazdin (2007) are not met. 
Purpose of the Review 
 
Investigating the possible mechanisms of change in therapy may enhance outcomes if the 
processes that are responsible for the positive symptom change are identified and can then be 
targeted.  As Kazdin (2007) indicated, strong research designs are needed in order to identify the 
mediators and mechanisms involved in psychotherapies.  This review seeks to gain an 
understanding of the study design and statistical methods used to establish mediators of group 
CBT.  A systematic review will be conducted as this procedure can address methodological 
questions by comprehensively identifying all relevant studies and examining the methods that are 
employed (Petticrew & Roberts, 2008).  Specifically, this review will address the question: What 
is the quality of the methodologies that are used to measure mediators of outcomes in cognitive 
behavioural group therapy for adults? Other aspects of the research methods in each study, such 
as whether a treatment fidelity measured is used, what statistical analyses are used, and what 
measurement tools are used, will also be explored. 





Data Sources and Search Strategy 
 
Following Perestelo-Perez’s (2013) recommendation to use more than two or three 
databases when conducting a systematic review, several sources were accessed.  PsychINFO, 
Pubmed, Web of Science, CINAHL, Proquest Nursing & Allied Health Source, and Evidence 
Based Medicine (EBM) Reviews were searched.  These databases were chosen based on their 
relevance to psychotherapy outcomes and group therapy.  In addition to the electronic database 
search, Google and Google Scholar were used to identify additional studies that were not 
contained in the journal databases.  In order to ensure that all relevant studies were considered 
and not missed due to imperfect indexing in the databases, the reference lists of all included 
studies were hand searched for additional published research.  As the Cochrane Collaboration 
Group suggests also viewing the references of other relevant systematic reviews during the study 
identification phase (Van Tulder et al., 2003), the references listed in the review by Johansson 
and Hoglend (2007) were also examined to determine whether studies met the inclusion criteria. 
In order to locate articles that examine a mediator or mechanism of change in group CBT 
for adults, various search terms were used to address each of the following key components: a 
cognitive-behaviourally based treatment, group treatment format, and evaluation of 
mediators/mechanisms.  These search terms are presented in Table 10.  They were entered 
altogether into each database, and the MeSH terms outlined in Table 10 were added to the search 
terms when it was possible.  The location of the search terms was not limited to titles and 
abstracts, as the terms were searched for anywhere in an article. 





Search Terms Used to Represent Key Features of the Inclusion Criteria 
 
 
Key Categories Search Terms Entered 
Therapy based on 
cognitive-behavioural 
principles 
cognitive-behav* therap* OR cognitive behav* therap* OR CBT 
OR cognitive-behav* treatment OR cognitive behav* treatment OR 
cognitive-behav* intervention OR cognitive behav* intervention 
Group treatment format
a
 "group treatment" OR "group therapy" OR "group session" OR 
"group format" OR "group psychotherapy" OR "group intervention" 
Mediator or mechanism of 
change 
mediat* OR mechanism 
MeSH terms “psychotherapy, group” and “cognitive psychotherapy” 
 
a 
The group format terms were in quotations due to the large number of studies that include the 




The search was further limited to articles published in English between 2000 and May 
 
2014.  An initial search identified 122 articles in PsychINFO, 63 articles in Pubmed, 89 articles 
in Web of Science, 4 articles in CINAHL, 92 articles in Proquest Nursing & Allied Health 
Source after further filtering the search by age group and the two MeSH terms, and 73 articles in 
Evidence Based Medicine (EBM) Reviews.  Google Scholar identified 13,100 articles. Since 
Google Scholar lists articles in order of their relevance, and the identified articles were 
demonstrating to be irrelevant part way through examination of the first 50 pages, only the first 
50 pages of results were examined (approximately 500 titles and abstracts).  Additionally, a 
general Google search was conducted, which generated 6 results. 
Inclusion and Exclusion Criteria 
 
Studies were required to meet the following inclusion criteria in order to be included in 
the review: (1) involve an adult sample (treatment groups must have an average participant age 
between 18 and 60); (2) assess a mediator variable at a minimum of one time point; (3) explicitly 
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state in the article that mediation or a mechanism of change was being analyzed; (4) assess 
outcomes following a form of cognitive behavioural therapy in a group format; (5) assess 
psychological outcomes; (6) publication between 2000 and May 2014; and (7) written in the 
English language.  Infant, child, adolescent, and geriatric populations were excluded in order to 
narrow the focus of the review, and because the largest number of published group CBT articles 
evaluating mediators/mechanisms were expected to involve an adult population.  The outcomes 
could be related to people of another age group (e.g., child behaviour as an outcome of a CBT 
parenting program), but the participants attending the treatment group had to be adults. 
Treatments or interventions were included if they were described to follow cognitive-behavioural 
principles or included cognitive and behavioural components.  Acceptance and Commitment 
Therapies that focused on accepting ones thoughts as opposed to challenging thoughts were 
excluded.  Though these treatments are variants of CBT, they were excluded in order to create a 
more focused review that explores treatments based on traditional CBT principles.  Family 
interventions that include both children and parents in the treatment sessions were excluded. 
Additionally, articles were only included if they specifically stated that the treatment was 
delivered in a group format.  Treatments with both individual and group sessions were still 
included if the treatment appeared to be primarily administered in a group format.  Psychological 
outcomes were defined as measured variables pertaining to: symptoms of mental disorders, 
aspects of mental health (e.g., self-esteem, stress), functioning in areas of one’s life (e.g., quality 
of life), or a physiological measure that was intended to reflect a psychological construct (e.g., a 
measure of cortisol to indicate stress).  Studies that only evaluated other types of outcomes (such 
as biological treatment adherence, or weight-loss) following a CBT based program were 
excluded.  Meta-analyses were also excluded from the present review. 
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Article Screening and Selection 
 
The primary reviewer conducted an initial screen of the articles that were identified in 
each of the databases.  This pre-selection phase consisted of examining the article title and 
abstract to determine if the article could possibly meet inclusion criteria.  The full text of some 
articles was viewed in this process if there was insufficient information in the abstract and title to 
adequately judge the article’s relevance. A total of 64 articles were identified as possibly meeting 
the inclusion criteria. One article contained two separate studies, both of which met inclusion 
criteria. Therefore, there were 65 studies examined in total. 
The inclusion criteria were applied in the next review stage.  A pilot phase was first 
conducted where two reviewers independently applied the inclusion criteria and extracted data 
for seven articles and then met to discuss their ratings.  An additional 18 articles were then 
independently reviewed, with 100% agreement for included and excluded articles. The first 
reviewer then applied the inclusion criteria to the remaining articles.  The reference lists of all 
the included articles were then searched and one additional article meeting inclusion criteria was 
found. 
Thus, a total of 29 articles (30 studies since one article contained 2 studies) met inclusion 
criteria for this systematic review.  Of the 64 articles that were saved from the pre-screening and 
then reviewed, 3 did not analyze a CBT based treatment, 12 evaluated treatments that were not 
delivered in group format, 11 did not investigate mediation, 4 were not within the desired age 
range, 5 did not evaluate psychological outcomes, and 1 article consisted of a family intervention 
that involved children in the treatment sessions. 
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Figure 2 outlines the screening process that led to the final 29 articles included in the 
review.  The saved articles were reviewed again to ensure they met inclusion criteria, and then to 
analyze and extract the relevant information. 
 
 






During the pilot phase of the review, the two reviewers independently extracted data for 
seven articles and then met to discuss their ratings.  Both reviewers had been unable to extract 
information from some of the articles due to limitations of the rating scheme.  The rating scheme 
and data record form were altered at this point in order to better address the variety of mediation 
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models that had been reviewed.  Disagreements were resolved by consensus.  An interrater 
reliability analysis was conducted to evaluate the design rating consistency between the two 
reviewers for the 10 articles that they both extracted data from, which indicated substantial 
agreement (Kappa = .767, p < .001). 
The information obtained from articles meeting inclusion criteria included: sample size, 
mean age of participants, primary diagnosis of participants if applicable, treatment 
characteristics, whether a treatment fidelity measure was included, the outcome and mediator(s) 
studied, the predictor in the mediation analyses if applicable, the measures used to assess the 
outcome(s), mediator(s), and predictor(s), whether there was a control group or not, whether 
there was random assignment, the type of statistical analysis employed and the study findings. 
Each study was also rated based on when potential mediation/mechanisms and outcomes were 
measured during the course of the treatment. 
Criteria for Evaluating Methodologies.  Kazdin (2007) proposed a system for rating the 
quality of studies that evaluate mediators based on when the outcome measures are assessed and 
when the mediator variable is assessed.  The present review uses the design categorizations presented 
by Kazdin (2007), with some slight modifications.  As this review only included studies that evaluate 
a mediation model, Kazdin’s first category of studies that assess outcomes but not potential 
mechanisms was excluded.  Thus, the study design categories of 1 to 4 in this paper correspond to 
Kazdin’s categories of 2 to 5.  Additionally, an “Other design variations” category was added in 
order to address mediation designs involving follow-up assessments that did not fit the criteria of 
categories 1 to 4. Lastly, specifications were added to Kazdin’s “Assessment of mechanisms during 
treatment” category as some designs included additional measurements of potential mediators and 
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outcomes, but the measurement time points did not meet the criteria of Category 3. The rating 
scheme used in this review is outlined in Table 11. 
Table 11 
Study Designs for Evaluating Mechanisms and Outcomes Based on Kazdin's (2007) 
Categorization 
 
Measurement time points 
 
Design categories Pre During Post 
 
1. Concurrent study of 






2. Assessment of mechanisms 
during treatment 
 
3. Assessment of mechanisms 
and outcomes during treatment 
















4. Assessment of mechanisms 










5. Other design variations Mediators and/or outcomes assessed during a follow-up period 
and varying other time points that do align with the above 





In accordance with Kazdin’s (2007) descriptions of the design categories, Designs 1 and 
 
2 in this review are not able to assess the time sequence of change in the mediator variable 
compared to change in the outcome variable.  The third design is able to capture the time 
sequence of change in the potential mediator and outcome from pre- to mid- to post- treatment. 
However, there are still some limitations to Design 3 as the mediator and outcome could change 
at different rates between the assessment points.  Thus, the fourth design is considered the most 
thorough since it consists of potential mechanisms and outcomes being assessed at almost every 
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session.  This design provides information about the pattern of change in each construct over the 
course of therapy (Kazdin, 2007). 
Data Synthesis 
 
A narrative synthesis of the data was conducted.  Following the narrative synthesis 
recommendations of Petticrew and Roberts (2008), studies were grouped based on design, and 
then the studies within each category were analyzed and information across the studies was 
synthesized.  Studies were grouped according to their mediation/mechanism measurement rating, 
and then each of these groups was analyzed to obtain a better understanding of the types of 
designs within each category.  Specifically, the analyses employed, the quality of the methods, 
and the number of mediators investigated within each study was examined within each design 
category.  Across all studies, all extracted information was synthesized, presented in tables, and 
discussed.  Studies were also grouped with other studies investigating similar outcomes and 
mediators in order to summarize the information available on a particular construct.  This 
synthesis provides an overall understanding of how mediation and mechanisms of change have 
recently been measured in the context of group CBT.  Thus, the review sought to inform 
researchers of how change is typically measured, and how methodological improvements can be 
made in order to enhance the quality of future studies. 
Results 
 
Description of the Studies 
 
Sample and Treatment Characteristics. As demonstrated in Table 12, sample and 
treatment characteristics varied greatly across the 30 included studies.  Participants in some 
studies did not need to meet diagnostic criteria for a particular disorder to be included in the 
treatment program, while participants in other studies had received psychological or medical 
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diagnoses such as irritable bowel syndrome (IBS), breast cancer, obsessive-compulsive disorder 
(OCD), or social anxiety disorder (SAD).  As such, the group treatments based on cognitive- 
behavioural principles all varied in the specific symptoms that they were designed to address. 
Only one study consisted of parents participating in an intervention to learn parenting skills and 
improve their children’s conduct behaviours.  Information regarding medication use among 
participants during the course of treatment was not available for all of the studies.  However, 12 
studies explicitly stated that participants taking medication were included, while only 1 study 
outlined the use of medication in their exclusion criteria.  The total sample sizes of the studies 
ranged from 35 to 353 participants (M = 117.90, SD = 70.08), while participant mean age ranged 
from 32.00 to 59.40.  Treatment durations ranged from 4 to 24 weeks (M = 11.48 weeks, SD = 
4.60, mode = 10 and 12 weeks). Number of sessions ranged from 5 to 24, with a mean of 11.98 
sessions (SD = 3.89).  Ten sessions was most frequently reported though 10 and 12-week 
programs were equally as common, as some programs allotted more time in between the last 
sessions and some programs did not run sessions once per week. 
Mediator Variables. The types of mediators examined as well as the designs used to 
assess mediation differed among the articles.  Eleven studies examined a cognitive variable as a 
mechanism of change, while other examined mediators included behavioural and/or affective 
variables such as fear, engagement, self-efficacy, skills acquired, neurological abilities, 
avoidance, direction of attention, attachment, group closeness, quality of life, alliance, 
symptomatology, interpersonal problems, and homework compliance. 









Authors Sample Size Mean Age Primary Diagnosis Treatment Type
a
 Treatment Duration Fidelity 
Measure (Yes 
or No) 
Aderka et al. (2013) 177 37.6 Generalized SAD GCBT 14 weekly sessions N 
 
Antoni et al. (2006) 
 
199 (tx group: n=107, 












Delsignore, Carraro, Mathier, 















Dwyer, Hornsey, Smith, Oei, & 






Anxiety or mood disorder 
 
GCBT for depression, 
GCBT for anxiety 
 













GCBT for mood 
 





Dupart, Jimenez, & Thompson 
(2008) 
 
118 (tx group: n=97, 






Coping with Caregiving 
 















Incredible Years program 
 













CBSST to improve 
functioning in people with 
schizophrenia 
 




Hedman et al. (2013) 
 














90 (30 completers in 






















Group and individual CBT 
for OCD 
 
15 weekly 2-hour sessions (for 










Depression, some comorbid 
 
Coping with Depression 
 
10 sessions that were 90 min 
 
N 
MECHANISMS OF CHANGE WITHIN GCBT 77  
 
 SAD course long (2 were individual, 8 
were group format) 
 
 








GCBT for depression 
 





Labus et al. (2013) 
 
Marquez-Gonzalez, Losada, Izal, 
 
















5 weekly 2-hour sessions 
 





Perez-Rojo, & Montorio (2007)       
 
McEvoy, Burgess, & Nathan 
(2014) 
 
199 (individual CBT: 





Depression or anxiety 
disorder 
 
Transdiagnostic GCBT for 
anxiety or depression, 
individual CBT 
 













CBGT for SAD 
 




Meulenbeek, Spinhoven, Smit, 217 (tx group: n=109, 42 Subthreshold or mild panic "Don't Panic" course 8 weekly 2-hour sessions N 
Wan Balkom, & Cuijpers (2010) control group: n=108)  disorder symptoms    
 
 
Phillips et al. (2011) 128 (tx group: n=65, 
control group: n= 63) 
49.69 Breast cancer CBSM 10 weekly 2-hour sessions N 
 
 
Phillips et al. (2008) 128 (tx group: n=63, 
control group: n= 65) 








PTSD or sub-threshold 
PTSD and drug/alcohol 
dependence 
 
"Seeking Safety" -group tx 
for trauma and substance 
abuse 
 
Twice weekly 75-90 min 










Neurotic, stress-related and 
somatoform disorders, mood 
disorders, other disorders 
 
GCBT for patients with 
anxiety and depressive 
symptoms 
 












Meta-cognitive therapy for 
adult ADHD 
 




Smits, Powers, Cho, & Telch 
(2004) 
 
130 (tx group: n=90, 




Panic disorder with 
agoraphobia 
 
GCBT for panic disorder 
and agoraphobia 
 








Taft, Murphy, King, Musser, & 
DeDeyn (2003) 
107 36.22 N/A GCBT for partner violent 
men 
16 weekly 2-hour sessions N 
 









GCBT to address abusive 
behaviour 
 











Binge eating disorder 
 
GCBT or GPIP for binge 
eating disorder 
 




van Aalderen et al. (2012) 205 (MBCT: n=102, 
TAU: n=103) 
47.5 Depression Mindfulness-Based CBT 
with TAU 
8 weekly 2.5-hour sessions N 
 
Vreeswijk, Spinhoven, Eurelings- 

























GCBT for managing 
anxiety 
 




Note. CBSM = cognitive-behavioural stress management; CBSST = Cognitive- Behavioural Social Skills Training; MDTC = Modification of Dysfunctional Thoughts about 
Caregiving; GPIP = Group Psychodynamic Interpersonal Psychotherapy; HLM = hierarchical linear modeling; tx = treatment; WL = wait-list. 
 
a
Treatment Type and Treatment Duration are descriptions of the group, cognitive-behaviorally based treatment included in the study. Other treatment groups or control groups are 
not described in the table. 
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Study Design.  All five of the study design categories outlined in Table 11 were 
represented in the reviewed studies.  Design 1 was used most frequently as 43.33% of the 
included studies employed this type of research design.  The percentages of studies using the 
remaining designs were as follows: Design 2 = 23.3%, Design 3 = 6.7%, Design 4 = 10.0%, and 
Design 5 = 16.7%. Table 13 outlines the study characteristics within each design category. 
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Several studies used more than one of the listed statistical analyses 
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Statistical Analyses. Overall, product of coefficients approaches, which include the 
Sobel test, were used most often (by 40.0% of the studies), followed by the Baron and Kenny 
approach (33.3%), and then bootstrapping (23.3%). 
Quality of Methods.  The quality of the methodologies used in terms of treatment 
fidelity, the use of a control group, and random assignment to conditions was examined across 
the design categories.  Treatment fidelity measurement and inclusion of a control group were 
most common within the Design 1 category, while random assignment was most common among 
the Design 5 studies (see Table 13).  None of the studies using designs that can detect temporal 
antecedence of a mediator variable (Designs 3 and 4) used control groups, although one of these 
studies compared the group treatment to individual treatment.  Overall, these characteristics were 
not commonplace among the studies, as only 16.7% of all the included studies used a treatment 
fidelity measure, 43.3% used a control group, and 56.7% used random assignment. 
Design 1.  Studies falling within the first design category were generally very similar in 
structure as both the potential mediators and outcomes were measured at pre- and post- 
treatment.  One of the studies within this category (Granholm et al., 2008) assessed the outcome 
and mediator concurrently during a follow-up period instead of immediately after treatment 
completion, so the follow-up measurement was treated as a post-treatment measure. 
Additionally, the Antoni et al. (2006) study assessed a mediator and outcomes at the pre-, post-, 
and follow-up periods.  This study was categorized as a Design 1 study since there were no 
assessments during the course of therapy.  Almost half of the studies within this category 
(46.2%) assessed more than one potential mechanism. The most frequently used statistical 
analyses within this category were the Baron and Kenny approach, product of coefficients tests, 
and bootstrapping (see Table 13). 
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Design 2.  Within the Design 2 category, three studies evaluated outcomes at pre- and 
post- treatment only, while the potential mediator was assessed only once during the course of 
the treatment.  Other methodologies that were still classified as a Design 2 included studies 
where the outcomes are measured multiple times, but the mediator is only measured once during 
treatment (e.g., Westra et al., 2007) and studies where the mediator is measured multiple times 
but the outcomes are only measured pre- and post- treatment (e.g., Dwyer et al., 2011(Study 2); 
Tasca et al., 2006). Four of the studies within this category (57.1%) examined more than one 
potential mediator. The Baron and Kenny approach and Sobel test were used often among 
Design 2 studies. 
Design 3.  The two studies included in this category used the exact same design where 
potential mediators and outcomes were assessed at pre-, mid-, and post-treatment.  Neither of the 
two studies examined more than one potential mediator. SEM and hierarchical regression were 
used by the Design 3 studies. 
Design 4.  None of the studies assessed variables at ‘most’ sessions as all three of the 
studies included in this category assessed potential mediators and outcomes at every single 
session.  The Hedman et al. (2013) and Kashdan and Roberts (2011) studies assessed multiple 
mediators, while the Moscovitch et al. (2005) article analyzed one mediator of change in an 
outcome and then conducted another mediation model where the mediator and outcome variables 
were switched.  Each of these three studies used multilevel models in their statistical analysis in 
order to address the session-by-session changes for each participant. Design 4 studies employed 
Baron and Kenny, Sobel test, other product of coefficients tests, and bootstrapping. 
Design 5.  Four of the reviewed studies were included in this category since they did not 
involve a pre-treatment measurement of outcomes.  The Phillips et al. (2011), Phillips et al. 
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(2008), and Sawaya et al. (2013) studies examined change in a variable during treatment as a 
mediator of change during the post-treatment to follow-up period only.  The study by Taft and 
colleagues (2004) examined a potential mechanism of change for the relationship between a pre- 
treatment variable (psychopathic traits) and a variable measured towards the end of treatment 
(therapeutic alliance).  In this model, the outcome variable was not measured at baseline so the 
potential mediator was not being investigated as a mediator of change during treatment.  Lastly, 
the Labus et al. (2013) article examined outcomes from pre- to follow-up treatment only, while 
the potential mediators were assessed at different time points.  Generally, the articles in this 
category did not fit Designs 1 to 4 due to the focus on the follow-up period.  Forty percent of 
these studies investigated more than one mediator. Studies in the Design 5 category most 
frequently used bootstrapping. 
Article Findings Grouped by Treatment Type, Outcomes Studied, and Mediators Studied 
 
As 18 studies examined a mediator within GCBT for anxiety or depression (see Table 14 
for study details), patterns and trends among these studies were examined.  Five of the articles 
involved patients with Social Anxiety Disorder (SAD) diagnoses, and four of these involved a 
treatment that was specifically tailored to address SAD symptoms. It is important to note that the 
following summaries of study findings may state that mediation was supported, but these 
findings are actually referring to statistical mediation being supported. Within the SAD-focused 
studies, significant mediators of symptom improvement from pre- to post- treatment included 
changes in one’s thoughts about the negative consequences of social situations (estimated social 
cost; Hoffman, 2004), changes in self-focused attention and anticipatory and post-event 
processing (Hedman et al., 2013), and fear at mid-treatment as a mediator of changes in 
avoidance (Aderka et al., 2013). Anticipatory processing refers to thoughts preceding a social 
MECHANISMS OF CHANGE WITHIN GCBT 84  
 
 
situation where the encounter is expected to be negative, while post-event processing refers to 
replaying social situations after they occur (as cited in Hedman et al., 2013).  Additionally, 
session-by-session social anxiety symptoms were examined as a mediator and were shown to 
mediate the session-by-session improvements in depressive symptoms (Moscovitch et al., 2005). 
A fourth study that focused on GCBT for SAD found that the relationship between baseline 
perceived internal control about change in therapy and post-treatment symptom outcomes was 
partially mediated by therapy-related self-efficacy and therapy engagement for patients with 
SAD (Delsignore et al., 2008). Evidently, there is high variability in the mediators examined for 
patients with SAD who are receiving GCBT. Only two of the SAD-focused studies (Hedman et 
al., 2013; Moscovitch et al., 2005) used designs that are able to address the temporal sequence of 
change. 
Five studies evaluated mediation of treatment for mood or depression.  Three of these 
studies investigated similar mediator variables, while all five studies included depressive 
symptoms as at least one of the outcome measures.  However, the Dwyer et al. (2011), Kashdan 
and Roberts (2011), and Kwon and Oie (2003) studies used a predictor variable in their models 
that differed from the outcome variables.  Thus, these articles do not specifically address a 
mediator of the change in depressive symptoms from pre- to post- treatment.  The variability in 
the mediation models of these three articles precludes the ability to compare their findings.  Of 
the remaining two articles, both found support for skills as mediators of change in depressive 
symptoms, while one also found support for cognitive variables as mediators of change.  More 
specifically, van Aalderen et al. (2012) found worry, rumination, and an increase in the 
mindfulness skill, “accept without judgement”, to significantly mediate change in depression 
following a mindfulness-based CBT.  Gallagher-Thompson and colleagues (2008) found skill 
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effectiveness to mediate the relationship change in depressive symptoms following a Coping 
with Caregiving course for people who are caretakers of family members with dementia.  Again, 
though these five studies consisted of patients with depressive symptoms who received group 
treatment based on cognitive-behavioural principles for depression, and depressive symptoms 
were used as the outcome variables, there was little overlap in the mediation models due to the 
different predictors and mediators examined. 
Homework was analyzed as mediator of treatment outcomes in three of the reviewed 
studies.  Each of the therapies in these studies differed regarding the symptoms they were 
designed to address.  Thus, homework was investigated as a mediator of different variables, 
including change in inattention for adults with ADHD (Solanto et al., 2010), the relationship 
between early therapist alliance ratings and reduced psychological abuse following CBT for 
partner violent men (Taft et al., 2004), and the relationship between pre-treatment expectancy for 
anxiety symptoms to change and initial symptom change (Westra et al., 2007). Homework 
completion was statistically supported as a potential mediator in the Solanto et al. and Westra et 
al. studies, while it was a partial mediator in the study by Taft and colleagues.  These three 
studies were all included in the Design 2 category, so findings should be interpreted along with 
the limitations of the designs. 













(Yes or No) 
Mediation measures Outcome measures Statistical Analysis Rating
a
 
Aderka et al. (2013) N N/A Y BSPS- fear subscale BSPS -avoidance subscale Bootstrapping 2 
 








Bernese scale completed 
by the therapist and a 
subscale of the TBK 
 
LSAS, Generalized Self-Efficacy 
Scale, SCL-K-9 
 













CCL-A and CCL-D 
 



































CES-D, PSS-10, RMBPC-CB 
 
Z scores, Sobel test 
 
1 
Hedman et al. (2013) N Individual 
CT 
Y 4 subscales of the 
SPWSS 
Social anxiety item on the 
SPWSS 
Moderated mediation and 

















Linear regression following 
Kraemer’s recommendations, 
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Moscovitch et al. (2005) N N/A N 1) LSAS 2) BDI 1) BDI, 2) LSAS Multilevel growth curve 














coping, and MASTERY 
 
PDSS-SR, HADS-ANX, and MI 
 























Smits et al. (2004) Y N Y ASI, BSQ Texas Panic Attack Record 
Form, SPRAS, FQ-Ago, SDS 
Baron & Kenny 1 
 









Rumination on Sadness 









Westra et al. (2007) N N/A N 1) Homework scale 
developed by authors, 2) 
one standard deviation 
reduction in symptoms 
ASI, FNEB, PSWQ, BDI-II Baron & Kenny, Goodman’s 
unbiased solution 
2 
Note. BSPS = The Brief Social Phobia Scale, Scale TBK = Questionnaire on Control Expectancies in Psychotherapy, LSAS = Liebowitz Social Anxiety Scale, SCL-K-9 = 
Symptom-Checklist, CCL-A = Cognitions Checklist – anxiety subscale, CCL-D = Cognitions Checklist – depression subscale, ZSDS = Zung Self Rating Depression Scale, BAI = 
Beck Anxiety Inventory, QOLI = Quality of Life Inventory, BDI = Beck Depression Inventory, SUQ = Skill Utilization Questionnaire CES-D = Centre for Epidemiological Studies 
- Depression Scale, PSS- 10 = Perceived Stress Scale, RMBPC = Revised Memory and Behaviour Problem Checklist – Conditional Bother, SPWSS = Social Phobia Weekly 
Summary Scale, SCQ = Social Cost Questionnaire, SPAI = Social Phobia and Anxiety Inventory, RAS = Responsibility Attitude Scale, TAFS = Thought Action Fusion scale 
(TAFS), Y-BOCS = Yale-Brown Obsessive Compulsive Scale, FAQ = Focus of Attention Questionnaire, ECR = Experiences in Close Relationships Inventory, IOS = Inclusion of 
Other in the Self Scale, BDI-II = Beck Depression Inventory-II, ATQ = Automatic Thoughts Questionnaire, DAS = Dysfunctional Attitudes Scales, DTCQ = 
Dysfunctional Thoughts about Caregiving Questionnaire, HAq-II = Helping Alliance Questionnaire 2, PAI = Panic Appraisal Inventory, PDSS-SR = Panic Disorder Severity Scale 
– Self Report, HADS-ANX = Hospital Anxiety and Depression Scale –anxiety subscale, MI = Mobility Inventory, CAPS = Clinician-Administered PTSD Scale (CAPS), ASI = 
Anxiety Sensitivity Index, BSQ = Body Sensations Questionnaire, SPRAS = Sheehan Patient-Rated Anxiety Scale, FQ-Ago = Fear Questionnaire – Agoraphobia scale, SDS = 
Sheehan Disability Scale, PSWQ = Penn State Worry Questionnaire, KIMS = Kentucky Inventory of Mindfulness, HAMD = Hamilton Rating Scale for Depression, , FNEB = 
Fear of Negative Evaluation Scale Brief Version 
 
a 
Ratings are as follows: 1 = Concurrent study of mechanisms and outcomes, 2 = Assessment of mechanisms during treatment, 3 = Assessment of mechanisms and outcomes 
during treatment, 4 = Assessment of mechanisms and outcomes at all or most sessions, 5 = Other design variations 
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Findings within the Highly Rated Mediation Designs 
 
The highest quality mediation studies are ones that use level 3 or 4 designs in order to 
address the temporal sequence of change in the mediator and outcomes, while also comparing to 
a control group, using randomization, and assessing treatment fidelity.  Of the Design 3 and 4 
categories, only one study met most of these criteria.  The aforementioned Hedman et al. (2013) 
article compared GCBT and Individual Cognitive Therapy for SAD, randomly assigned 
participants to groups, and measured treatment fidelity.  The quality of this study was further 
enhanced by their assessment of multiple mediators.  Multilevel moderated mediation analyses 
were used to take into account the session-by-session changes in social anxiety and the potential 
mediators, and a product of coefficients test was used to evaluate the significance of the indirect 
effect.  For the GCBT condition, changes in self-focused attention and in anticipatory and post- 
event processing mediated the changes in social anxiety.  This study has been described in detail 
since its high-quality nature provides strong support for its findings.  Nevertheless, other criteria 
as outlined by Kazdin (2007) are still required in order to determine whether changes in self- 
focused attention and anticipatory and post-event processing are true mechanisms of change in 
GCBT for SAD. 
Discussion 
 
This review examined study design characteristics for published articles examining 
mediators of GCBT for adults from the year 2000 to the present time.  Mechanisms of change 
have been evaluated with designs that range from measuring mediators and outcomes at pre- and 
post- treatment only, to measuring mediators and outcomes at every session.  However, the most 
frequently used design was one that consists of potential mediators and outcomes measured at 
pre- and post- treatment only.  The second most commonly used design was one where outcomes 
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were measured pre- and post- treatment with the potential mediator measured during treatment 
only.  Considering how both of these designs are unable to distinguish the temporal patterns of 
change in the mediator compared to outcome variables (Kazdin, 2007), the results cannot 
conclusively demonstrate mediation even if the statistical analysis was significant.  As only three 
studies employed designs where the mediator and outcomes were measured at every session, 
there is a need for more studies to use these types of rigorous designs.  This finding is consistent 
with the assertions of Johanson and Hogeland (2003), as well as Kazdin (2007), who have all 
bolstered the need for mediation analyses to use designs that take temporal sequence into 
account. 
Similarly, two of Kazdin’s (2007) other criteria for establishing mediation, specificity and 
consistency, were not always demonstrated.  The specificity criterion, which entails a need for 
other potential mediators to be examined and not supported, was addressed by 13 of the studies in 
this review.  Thus, 13 studies examined multiple mediators while 17 assessed a single mediator.  
Support of the consistency criterion was not evident in this review, as there was very little 
overlap in the types of mediators assessed.  There seems to be no exact replication of results 
among the 30 studies.  This could be due to the fact that the review is limited by a group format 
of CBT. It may also indicate a tendency for journals to publish novel research at the expense of 
replication research. Perhaps mediation analyses have been conducted in individually delivered 
CBT that could provide further support of the potential mediators recognized within the studies 
in this review. 
There was wide variation among studies analyzing GCBT, further highlighting the need 
for replication.  For example, there were five studies investigating mediators of change in GCBT 
for SAD, five studies examining mediators of change for depression, and three studies examining 
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homework compliance as a mediator of change, yet there were few similarities across the studies 
within these groups.  However, the variation among the reviewed studies, such as the different 
types of cognitive-behaviourally based interventions that are designed to address an array of 
psychological and physical symptoms, underscores the wide application and utility of cognitive- 
behavioural principles.  Even though this variation precluded drawing conclusions about specific 
mediators in the present review, it also draws attention to the many ways that features of CBT 
are applied. 
 
Studies within the Design 3 and 4 categories were expected to provide the highest level 
of evidence for mechanisms of change in GCBT.  However, it was apparent that few of these 
studies used other high-quality methods such as comparison to a control group, randomization, 
or inclusion of a treatment adherence measure.  Therefore, despite using more sophisticated 
methods for evaluating mediation, some studies did not use other strong methodological features 
that are necessary in order to identify true mechanisms of change. This finding concurs with 
Kraemer, Wilson, Fairburn, and Agras’ (2002) observation, who highlighted the dearth of 
randomized controlled trials (RCTs) investigating mediators of treatment outcomes.  Kraemer 
and colleagues referred to uncontrolled studies as merely “hypothesis-generating” since they 
cannot provide robust evidence but they can provide helpful information regarding which 
potential mediators should be further evaluated in “hypothesis-testing studies” (RCTs). 
According to this logic, the current literature regarding change in GCBT could be viewed mostly 
“hypothesis-generating” in nature, since the potential mechanisms identified in the Design 3 and 
4 studies should be further evaluated with rigorous methodologies. 
 
Additionally, review of the statistical mediation analyses used in each of the articles 
indicated some room for improvement, as causal steps methods and some product of coefficients 
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tests that assume a normal distribution were frequently used in place of more appropriate 
statistical techniques.  However, bootstrapping approaches - which have fewer limitations - were 
also used by a large number of studies.   Some other more contemporary statistical approaches 
were also evident in the reviewed studies. 
The disconnect between the best research methods for assessing mediation and how 
mediation is actually assessed in current literature may stem from the practical limitations of 
measuring mediating and outcome variables during the course of therapy.  Researchers utilizing 
organization-based treatment groups (i.e., “clinical data”) use clients as participants.  Competing 
priorities and demands may influence the feasibility of the research project.  For example, the 
observed tendency to have participants complete measures at pre- and post-treatment only, may 
be due to concerns about time restrictions, rapport with the clients, or worry of placing additional 
“burden” on clients.  Alternatively, some clients may not wish to complete measures at every 
session.  In general, the nature of clinical data collection is fraught with several barriers.  Many 
treatment programs are delivered within a larger mental health clinic or hospital that has 
regulations, policies, and ethical guidelines in place that may impact how and when data is able 
to be collected.  Sometimes concerns are raised about the impact of completing a questionnaire 
on patients’ symptoms (Valderas et al., 2008), or the ethics of collecting clinical data when 
sample sizes will be small and analyses may lack power (Halpern et al., 2002). Another reality 
of clinical data collection is that using control groups and randomization may not always be 
possible.  Considering the plethora of barriers to this type of research, it seems as though 
selecting very brief measures to address multiple mediators would be particularly important 
when attempting to assess potential mediators of change in treatment at every session. 





Though this review provides insight regarding the state of mediation analyses within 
GCBT, there are some noteworthy limitations.  First, the review may be impacted by publication 
bias, as 29 of the included studies were articles that had been published in a journal, while one 
study was a dissertation published online.  Although the initial search included online resources 
that do not only contain peer-reviewed, published articles, an extensive search of unpublished 
work was not conducted.  The potential limitation this poses is that only studies with “positive 
results” were published. 
A second methodological limitation involves the reviewing process.  It is a strength of the 
study that a second reviewer also rated articles, but it is a limitation that there were 40 articles 
reviewed by only one reviewer.  In addition, the interrater reliability analysis was conducted of 
the study design ratings only.  The other extracted information was examined for differences and 
corrected when disagreements occurred, but that information was not included in a reliability 
analysis. However, this extracted data was factual in nature and did not require rating or 
interpreting the information, thus reducing the likelihood of inference-related extraction errors. 
Future Research 
As there was very little overlap among the mediation variables studied in all 30 mediation 
models, there is certainly a need to replicate findings.  In particular, the potential mediators 
supported by rigorous session-by-session measurement methods (i.e., the results of Hedman et 
al., 2013 and Moscovitch et al., 2005) could become supported as true mediators, if these results 
were replicated several times.  As some evidence has suggested there could be different 
mechanisms of change at work in group psychotherapy compared to individually-delivered 
formats, it is important for mediation to be examined further in the group treatment context. 
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Moreover, the characteristics of the reviewed studies suggests that future researchers 
assessing statistical mediation should be particularly cognizant of the design they use, so that 
designs are selected that can detect temporal antecedence of the mediator. The type of statistical 
mediation analysis should also be thoroughly considered, as some of the most widespread 
techniques may not adequately assess indirect effects. Finally, authors’ description of study 
methods could also become more explicit. For example, the importance of clearly reporting 
when participants completed each measure, reporting which measurement time points were used 
in mediation analyses, and reporting when change score were being used, was noted in this 
review process. Future research should attempt to explicitly outline this information so that 




Assessing potential mediators or mechanisms of change is essential to understanding 
what it is that works in GCBT.  The findings of this review highlight the need for Kazdin’s 
(2007) criteria for establishing mediation to be addressed in current research designs.  In 
particular, the principles of temporal sequence, specificity, and consistency appear to be in great 
need of consideration when conducting mediation research.  As this review found that the more 
sophisticated mediation designs lack other methodological features, there is also a need for RCTs 
that assess potential mediators and outcomes at every session.  Despite the noted areas for 
improvement and directions for future research, important information has been generated by 
each of the reviewed studies.  Identifying mechanisms of change is a process that occurs 
overtime through continuous hypothesis building, testing, and replication of results.  The current 
 
GCBT mediation literature provides a foundation for future studies to build upon in order to 
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identify true mediators of change, and then to ultimately understand the mechanisms that lead to 
change during therapy. 





This thesis sought to better understand how change occurs in GCBT for anxiety and how 
change is measured in recent literature.  Two studies were conducted to address these objectives. 
The first study did not find support for cognitive change as a mediator of anxiety treatment 
outcomes, nor did it support homework as a moderator of treatment outcomes. However, the 
small sample size was a significant limitation to this study. The systematic review of recent 
literature found that several published articles demonstrated that cognitive, affective, and 
behavioural variables mediate changes during GCBT for anxiety. However, the reviewed studies 
at best demonstrated statistical mediation and generally were not designed in a way that could 
establish mediation in a broader sense.  In both GCBT for anxiety and general GCBT, there 
remains a need to better understand how therapy leads to improved outcomes. 
Overall, the two conducted studies highlight the limitations of clinical research and data 
collection, while also presenting ways of improving this research.  There remains a need for 
future studies to adequately assess mediation and evaluate the efficacy and effectiveness of 
GCBT for anxiety. 
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Appendix A Information 
Letter for Time 1 
Study: Outcomes for group treatment of anxiety 
 
Investigators: Ms. Erika Portt and Dr. Amanda Maranzan, Lakehead University 
 
January 1, 2014 
 
Dear Potential Participant: 
 
My name is Erika Portt and I am a graduate student in the Clinical Psychology program at Lakehead 
University. I am currently working on a research project under the supervision of Dr. Amanda Maranzan. 
You have been contacted because you were referred for an anxiety group at St. Joseph’s Care Group. St. 
Joseph’s Care Group is partnering with Lakehead University to conduct this research study, and we invite 
you to participate. The purpose of the study is to find out the effects of the anxiety group. In order to find 
this out, we are inviting participation from clients who are currently in the anxiety group. 
 
Do I have to participate? 
 
No, you don’t have to participate in this study. If you decide not to participate, it will not affect your course 
of treatment at St. Joseph’s Care Group – you will still receive treatment. If you choose to participate, it is 
your own voluntary decision. You can refuse to participate in any or all parts of the study and you can 
withdraw from the study at any time (by contacting the researchers or not completing the questionnaires). 
You don’t have to answer any questions that you don’t want to. 
 
What will I be asked to do? 
 
You will be asked to fill out a questionnaire asking about demographic information (e.g., your age, sex, 
cultural affiliation). You will also be asked to fill out some questionnaires that ask about how you have 
been feeling (e.g., symptoms of anxiety, depression, panic, and thoughts about anxiety). In total, this will 
take you about 20 minutes. Halfway through the treatment and when the therapy group ends, you will be 
asked to complete the questionnaire packages a second and third time, which will again take about 20 
minutes each time. Therefore, participation would consist of completing the questionnaires three times for 
20 minutes each time, during the period that you are attending the therapy group. We are also requesting 
to access the three questionnaires that you complete for program evaluation (the Beck Anxiety Inventory, 
the Beck Depression Inventory and the Penn State Worry Questionnaire). We would match your program 
evaluation questionnaires to your questionnaire packages using a self-generated code so that your 
answers remain anonymous. Agreeing to participate therefore consists of completing the questionnaire 
packages and allowing the researchers to access three measures that you complete during the group. If 
you decide to participate, please complete the attached questionnaires and mail the package to the 
researchers using the pre-addressed and stamped envelope. If you do not want to participate, please do 
not complete or mail the questionnaires. By mailing in your questionnaire package, it will be assumed that 
you are consenting to participate in the study. 
 
Because the questionnaire asks about how you have been feeling, you may become more aware of 
emotional distress. If you become upset because of completing the questionnaire, please let the group 
leader know, or contact Intake at St. Joseph’s Care Group (807-624-3400). 
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To thank you for your participation, you have the option of receiving a $10.00 gift certificate for completing 
the questionnaires at all three data collection times. A separate, small form (provided) can be completed 
and returned to the researcher with your name and mailing address, to indicate each time that you 
complete a questionnaire package. 
 
How will my information be handled? 
 
The information we learn from this project will be used for a Master’s thesis at Lakehead University (Erika 
Portt). It will also be used to improve approaches to how we help people with anxiety disorders. 
 
All of the information you provide will be kept confidential. At no point will your name be associated with 
the information you provide. Your responses on the questionnaires will not be identifiable, and all data will 
be presented and published in aggregate (group) format. The contact information provided on a separate 
form will be used to mail the gift certificate to you, and to contact you for the follow-up questionnaire 
completion. However, this identifying form will not be associated with your questionnaire responses. 
 
Only the researcher team will have access to the data – no one at St. Joseph’s Care Group will be able to 
see  your  questionnaire packages. Your  data  will  be  stored in  a  locked filing cabinet at  Lakehead 
University for a period of five years, and then destroyed. 
 
What if I want further information? 
 
If you want further information about this study, you can contact Ms. Erika Portt by telephone at (613) 
243-8955 or by email at eportt@lakeheadu.ca. You can also contact Dr. Amanda Maranzan (supervisor) 
by telephone at (807) 343-8322 or by email (amaranzan@lakeheadu.ca). This research study has been 
reviewed and approved by the St. Joseph’s Care Group Research Ethics Board and Lakehead University 
Research Ethics Board. If you think that your rights as a participant have been violated you can contact 
St. Joseph’s Care Group Research Ethics Board for more information: Chair, Research Ethics Board St. 
Joseph's Care Group 580 N. Algoma St., Thunder Bay, Ontario P7B 5G4 phone: 807-343-4300 ext. 4723 
fax:  807-343-4376,  email  contact  for  REB  Chair:  REB_Chair@tbh.net.  You  may  also  contact  the 
Lakehead University Research Ethics Board for more information: 807-766-7289. 
 
If you would like a summary of the research results, please indicate so on the small form included in the 
questionnaire package. A summary will be sent to you at the end of the study (September 2014). 
 




Erika Portt, M.A. Student 
 










Mental health workers provide support 24 hours a day and can help you to access further services, as 
needed 
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Mental health workers provide counseling to individuals, couples, and families 
 




Mental Health Assessment Team 
 
At the Emergency Department (Thunder Bay Regional Health Sciences Centre) 
Mental health workers will assess your emergency mental health needs 
Thunder Bay Sexual Assault/Abuse Crisis Service 
(807) 344-4502 
 
Crisis workers are available 24 hours to give immediate help, as well as follow-up counseling, court 
advocacy and other services. Phone support for women who have experienced current ot past assault or 
abuse. 
 












Wednesday each month at Children’s Centre Thunder Bay – 283 Lisgar Street 
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Appendix B Information 
Letter for Time 2 
Study: Outcomes for group treatment of anxiety 
 
Investigators: Ms. Erika Portt and Dr. Amanda Maranzan, Lakehead University 
 
January 1, 2014 
 
Dear Potential Participant: 
 
You have been contacted because you were referred for an anxiety group at St. Joseph’s Care Group. St. 
Joseph’s Care Group is partnering with Lakehead University to conduct this research study, and we invite 
you to participate. The purpose of the study is to find out the effects of the anxiety group. In order to find 
this out, we are inviting participation from clients who are currently in the anxiety group. 
 
Note: As this is Time 2 of the study (mid-treatment), please do not complete the questionnaires in this 
package if you did not participate at Time 1. Time 1 consisted of filling out the questionnaire packages 
after the first therapy session. 
 
If you did participate at Time 1, we invite you to complete the questionnaires a second and third time. 
 
Do I have to participate? 
 
No, you don’t have to participate in this study. If you decide not to participate, it will not affect your course 
of treatment at St. Joseph’s Care Group – you will still receive treatment. If you choose to participate, it is 
your own voluntary decision. You can refuse to participate in any or all parts of the study and you can 
withdraw from the study at any time (by contacting the researchers or not completing the questionnaires). 
You don’t have to answer any questions that you don’t want to. 
 
What will I be asked to do? 
 
You will be asked to fill out a questionnaire asking about demographic information (e.g., your age, sex, 
cultural affiliation). You will also be asked to fill out some questionnaires that ask about how you have 
been feeling (e.g., symptoms of anxiety, depression, panic, and thoughts about anxiety). In total, this will 
take you about 20 minutes. Halfway through the treatment and when the therapy group ends, you will be 
asked to complete the questionnaire packages a second and third time, which will again take about 20 
minutes each time. Therefore, participation would consist of completing the questionnaires three times for 
20 minutes each time, during the period that you are attending the therapy group. 
 
We are also requesting to access the three questionnaires that you complete for program evaluation (the 
Beck Anxiety Inventory, the Beck Depression Inventory and the Penn State Worry Questionnaire). We 
would match your program evaluation questionnaires to your questionnaire packages using a self- 
generated code so that your answers remain anonymous. Agreeing to participate therefore consists of 
completing the questionnaire packages and allowing the researchers to access three measures that you 
complete during the group. If you decide to participate, please complete the attached questionnaires and 
mail the package to the researchers using the pre-addressed and stamped envelope. If you do not want 
to participate, please do not complete or mail the questionnaires. By mailing in your questionnaire 
package, it will be assumed that you are consenting to participate in the study. 
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Because the questionnaire asks about how you have been feeling, you may become more aware of 
emotional distress. If you become upset because of completing the questionnaire, please let the group 
leader know, or contact Intake at St. Joseph’s Care Group (807-624-3400). 
 
To thank you for your participation, you have the option of receiving a $10.00 gift certificate for completing 
the questionnaires at all three data collection times. A separate, small form (provided) can be completed 
and returned to the researcher with your name and mailing address, to indicate each time that you 
complete a questionnaire package. 
 
How will my information be handled? 
 
The information we learn from this project will be used for a Master’s thesis at Lakehead University (Erika 
Portt). It will also be used to improve approaches to how we help people with anxiety disorders. 
 
All of the information you provide will be kept confidential. At no point will your name be associated with 
the information you provide. Your responses on the questionnaires will not be identifiable, and all data will 
be presented and published in aggregate (group) format. The contact information provided on a separate 
form will be used to mail the gift certificate to you, and to contact you for the follow-up questionnaire 
completion. However, this identifying form will not be associated with your questionnaire responses. 
 
Only the researcher team will have access to the data – no one at St. Joseph’s Care Group will be able to 
see  your  questionnaire packages. Your data  will  be  stored in  a  locked filing cabinet at  Lakehead 
University for a period of five years, and then destroyed. 
 
What if I want further information? 
 
If you want further information about this study, you can contact Ms. Erika Portt by telephone at (613) 
243-8955 or by email at eportt@lakeheadu.ca. You can also contact Dr. Amanda Maranzan (supervisor) 
by telephone at (807) 343-8322 or by email (amaranzan@lakeheadu.ca). This research study has been 
reviewed and approved by the St. Joseph’s Care Group Research Ethics Board and Lakehead University 
Research Ethics Board. If you think that your rights as a participant have been violated you can contact 
St. Joseph’s Care Group Research Ethics Board for more information: Chair, Research Ethics Board St. 
Joseph's Care Group 580 N. Algoma St., Thunder Bay, Ontario P7B 5G4 phone: 807-343-4300 ext. 4723 
fax:  807-343-4376,  email  contact  for  REB  Chair:  REB_Chair@tbh.net.  You  may  also  contact  the 
Lakehead University Research Ethics Board for more information: 807-766-7289. 
 
If you would like a summary of the research results, please indicate so on the small form included in the 
questionnaire package. A summary will be sent to you at the end of the study (September 2014). 
 




Erika Portt, M.A. Student 
 
Amanda Maranzan, Assistant Professor 
 
Lakehead University 









Mental health workers provide support 24 hours a day and can help you to access further services, as 
needed 
 




Mental health workers provide counseling to individuals, couples, and families 
 




Mental Health Assessment Team 
 
At the Emergency Department (Thunder Bay Regional Health Sciences Centre) 
Mental health workers will assess your emergency mental health needs 
Thunder Bay Sexual Assault/Abuse Crisis Service 
(807) 344-4502 
 
Crisis workers are available 24 hours to give immediate help, as well as follow-up counseling, court 
advocacy and other services. Phone support for women who have experienced current ot past assault or 
abuse. 
 












Wednesday each month at Children’s Centre Thunder Bay – 283 Lisgar Street 
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Appendix C Information 
Letter for Time 3 
Study: Outcomes for group treatment of anxiety 
 
Investigators: Ms. Erika Portt and Dr. Amanda Maranzan, Lakehead University 
 
January 1, 2014 
 
Dear Potential Participant: 
 
You have been contacted because you were referred for an anxiety group at St. Joseph’s Care Group. St. 
Joseph’s Care Group is partnering with Lakehead University to conduct this research study, and we invite 
you to participate. The purpose of the study is to find out the effects of the anxiety group. In order to find 
this out, we are inviting participation from clients who are currently in the anxiety group. 
 
Note: As this is Time 3 of the study (end of treatment), please do not complete the questionnaires in this 
package if you did not participate at Time 1. Time 1 consisted of filling out the questionnaire packages 
after the first therapy session. 
 
If you did participate at Time 1, we invite you to complete the questionnaires at this time. 
 
Do I have to participate? 
 
No, you don’t have to participate in this study. If you decide not to participate, it will not affect your course 
of treatment at St. Joseph’s Care Group – you will still receive treatment. If you choose to participate, it is 
your own voluntary decision. You can refuse to participate in any or all parts of the study and you can 
withdraw from the study at any time (by contacting the researchers or not completing the questionnaires). 
You don’t have to answer any questions that you don’t want to. 
 
What will I be asked to do? 
 
You will be asked to fill out a questionnaire asking about demographic information (e.g., your age, sex, 
cultural affiliation). You will also be asked to fill out some questionnaires that ask about how you have 
been feeling (e.g., symptoms of anxiety, depression, panic, and thoughts about anxiety). In total, this will 
take you about 20 minutes. Halfway through the treatment and when the therapy group ends, you will be 
asked to complete the questionnaire packages a second and third time, which will again take about 20 
minutes each time. Therefore, participation would consist of completing the questionnaires three times for 
20 minutes each time, during the period that you are attending the therapy group. 
 
We are also requesting to access the three questionnaires that you complete for program evaluation (the 
Beck Anxiety Inventory, the Beck Depression Inventory and the Penn State Worry Questionnaire). We 
would match your program evaluation questionnaires to your questionnaire packages using a self- 
generated code so that your answers remain anonymous. Agreeing to participate therefore consists of 
completing the questionnaire packages and allowing the researchers to access three measures that you 
complete during the group. If you decide to participate, please complete the attached questionnaires and 
mail the package to the researchers using the pre-addressed and stamped envelope. If you do not want 
to participate, please do not complete or mail the questionnaires. By mailing in your questionnaire 
package, it will be assumed that you are consenting to participate in the study. 
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Because the questionnaire asks about how you have been feeling, you may become more aware of 
emotional distress. If you become upset because of completing the questionnaire, please let the group 
leader know, or contact Intake at St. Joseph’s Care Group (807-624-3400). 
 
To thank you for your participation, you have the option of receiving a $10.00 gift certificate for completing 
the questionnaires at all three data collection times. A separate, small form (provided) can be completed 
and returned to the researcher with your name and mailing address, to indicate each time that you 
complete a questionnaire package. 
 
How will my information be handled? 
 
The information we learn from this project will be used for a Master’s thesis at Lakehead University (Erika 
Portt). It will also be used to improve approaches to how we help people with anxiety disorders. 
 
All of the information you provide will be kept confidential. At no point will your name be associated with 
the information you provide. Your responses on the questionnaires will not be identifiable, and all data will 
be presented and published in aggregate (group) format. The contact information provided on a separate 
form will be used to mail the gift certificate to you, and to contact you for the follow-up questionnaire 
completion. However, this identifying form will not be associated with your questionnaire responses. 
 
Only the researcher team will have access to the data – no one at St. Joseph’s Care Group will be able to 
see  your  questionnaire packages. Your data  will  be  stored in  a  locked filing cabinet at  Lakehead 
University for a period of five years, and then destroyed. 
 
What if I want further information? 
 
If you want further information about this study, you can contact Ms. Erika Portt by telephone at (613) 
243-8955 or by email at eportt@lakeheadu.ca. You can also contact Dr. Amanda Maranzan (supervisor) 
by telephone at (807) 343-8322 or by email (amaranzan@lakeheadu.ca). This research study has been 
reviewed and approved by the St. Joseph’s Care Group Research Ethics Board and Lakehead University 
Research Ethics Board. If you think that your rights as a participant have been violated you can contact 
St. Joseph’s Care Group Research Ethics Board for more information: Chair, Research Ethics Board St. 
Joseph's Care Group 580 N. Algoma St., Thunder Bay, Ontario P7B 5G4 phone: 807-343-4300 ext. 4723 
fax:  807-343-4376,  email  contact  for  REB  Chair:  REB_Chair@tbh.net.  You  may  also  contact  the 
Lakehead University Research Ethics Board for more information: 807-766-7289. 
 
If you would like a summary of the research results, please indicate so on the small form included in the 
questionnaire package. A summary will be sent to you at the end of the study (September 2014). 
 




Erika Portt, M.A. Student 
 
Amanda Maranzan, Assistant Professor 
 
Lakehead University 









Mental health workers provide support 24 hours a day and can help you to access further services, as 
needed 
 




Mental health workers provide counseling to individuals, couples, and families 
 




Mental Health Assessment Team 
 
At the Emergency Department (Thunder Bay Regional Health Sciences Centre) 
Mental health workers will assess your emergency mental health needs 
Thunder Bay Sexual Assault/Abuse Crisis Service 
(807) 344-4502 
 
Crisis workers are available 24 hours to give immediate help, as well as follow-up counseling, court 
advocacy and other services. Phone support for women who have experienced current ot past assault or 
abuse. 
 












Wednesday each month at Children’s Centre Thunder Bay – 283 Lisgar Street 










Introduction to Study by Group Leader 
 
(To be read by group leader at the start of the first group treatment session). 
 
There is a research project being done by a Master’s student at Lakehead University. She is very 
interested in the treatment of anxiety, and she has asked me to read a paragraph to you about her research. 
She is inviting group members to participate in her research project or to learn more about the project. 
 
My name is Erika Portt and I am a graduate student in the Clinical Psychology program at Lakehead 
University. I am currently working on a research project under the supervision of Dr. Amanda Maranzan. 
We are wanting to find out the effects of this anxiety group. In order to find this out, we are inviting you 
to complete some questionnaires at the beginning, middle, and end of the group. The questionnaires ask 
about how you are feeling, for example, your mood and anxiety symptoms, and how you think about 
anxiety. It takes about 20 minutes to complete the questionnaires. If completing the questionnaires makes 
you feel worse, please let the group leader know. In order to thank you for your participation, we will be 
giving each participant who completes the study a $10 gift certificate. 
 
You don’t have to participate in this research – if you decide not to, you can still participate in this group 
and all other treatments here. The group leader will not be able to look at your questionnaires so please let 
her know if there is something important she should be aware of. 
 
If you would like more information about the study, please contact me. The questionnaire packages also 
contain an information letter that describes the study in greater detail. We are inviting everyone to take a 
package with them to learn more about the study. You can read the information letter at home to decide if 
you would like to participate or not. If you don’t want to participate, simply do not fill out the 
questionnaires and do not mail them in. 
 
A drop off box is provided to place the questionnaire package in if you do not want to participate or to 
find out more about the study. We are encouraging everyone to take a package so that your choice to 
participate or not remains private. 
 





Script to Notify Clients of Questionnaire Packages at Midtreatment and Posttreatment 
 
(To be read by the group facilitator at the end of the mid-treatment session) 
 
As we mentioned in the first session, there is a Lakehead University who is conducting a study about the 
treatment of anxiety. Since we are now half-way through the treatment, this is the second time point for 
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the questionnaire packages to be completed. If you participated at Time 1, and are interested in continuing 
to participate, please complete a questionnaire package again and mail it to the researchers. If you did not 
participate at Time 1, or wish to stop participating, then do not complete the questionnaire packages. Your 
participation is voluntary so you can stop participating at any time. 
 
We are asking everyone to take a package on your way out the door so that we do not know who is 
participating. However, there is a drop off box to put the questionnaire package in if you are not 
participating. Please let us know if you have any questions. 
 
(To be read by the group facilitator at the end of the last session) 
 
As we mentioned in the first session and at mid-treatment, there is a Lakehead University who is 
conducting a study about the treatment of anxiety. Since we are now at the end of the treatment, this is the 
third time point for the questionnaire packages to be completed. If you participated at both Time 1 and 
Time 2, and are interested in continuing to participate, please complete a questionnaire package again and 
mail it to the researchers. If you did not participate at Time 1 and Time 2, or wish to stop participating, 
then do not complete the questionnaire packages. Your participation is voluntary so you can stop 
participating at any time. 
 
We are asking everyone to take a package on your way out the door so that we do not know who is 
participating. However, there is a drop off box to put the questionnaire package in if you are not 




Script to Explain Codes during Program Evaluation 
 
(To be read by group leader before program evaluation measures are completed) 
 
As there is a study being conducted by a student at Lakehead University, we are asking you to answer 
three questions to generate a code. This code is used to match the program evaluation information to the 
other questionnaire data, for people who are participating in the study. If you are not participating in the 
study, this code will not be relevant and your information will not be used. By having everyone generate 
the code right now, it protects your privacy by preventing us from knowing who is participating and who 
is not. Please let us know if you have any questions or concerns. 
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Appendix E Demographic 
Questionnaire 
Thank you for participating in this research study. 
 
Your participation is voluntary. You do not have to complete any questions that you feel 
uncomfortable completing. 
 
The first three questions will help us create a unique code to match your questionnaires without 
having to ask your name or other identifying information. 
 
1.  First letter of mother’s maiden name (e.g., if your mother’s maiden name is Smith, you 
would put “S”):    
 
2.  Street number of the house/apartment you lived in while growing up (e.g., if you grew up 
at 15 Yonge St, you would put “15”):    
 
3.  First letter of the street you now live on: (e.g., if you currently live at 29 Barclay Ave, you 
would put “B”)    
 
4.  Sex: □ Male □ Female 
 
 
5.  Age:   (years) 
 
 




   Aboriginal (First Nation, Inuit, Metis) 
 
   Arab/West Asian (e.g., Armenian, Egyptian, Iranian, Lebanese) 
 
   Black (e.g., African, Haitian, Jamaican) 
 
   Chinese 
 
   Filipino 
 
   Japanese 
 
   Korean 
 
   Latin American 
 
   South Asian 
 
   South East Asian 




  White (Caucasian) 
 
   Other (please specify:   _) 
 
 
7.  Are you now □ Married/common-law □ Separated 
□ Widowed □ Divorced 
□ Never married 
 
8.  What is the highest level of education you have completed? 
□ High school □ Some college/university 
□ College/university □ Post graduate degree 
 
 
9.  What was your total household income from all sources, before taxes, last year? 
□ Below $20,000 □ $60,001 - $80,000 
□ $20,001 - $40,000 □ $80,001 - $100,000 
□ $40,001 - $60,000 □ $100,001 + 
 
 
10. Employment:  
□ Work full-time □ Work part-time 
□ Retired □ Do not work 
 
 
11. Have you ever been diagnosed with a psychological, emotional, or psychiatric condition? 
□ No □ Yes 
 
If “yes”, please list:    
 
12. Are you starting the anxiety disorder group today? 
□ Yes □ No – I am on the waiting list for the next group 
 
 
13. Besides the anxiety disorder group, are you receiving any other types of treatment? 
□ No □ Yes - medication 
 
□ Yes – individual therapy/counselling 
 
□ Yes –group therapy/counselling 
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□ Yes – other type of treatment (specify:   ) 





































Positive and Negative Affect Schedule (PANAS) 
 




This scale consists of a number of words that describe different feelings and emotions. Read each 
item and then circle the appropriate answer next to that word.  Indicate to what extent you have felt 
this way during the past few weeks. 
 
1 = Very slightly or not at all 
2 = A little 
3 = Moderately 
4 = Quite a bit 






























































































































































































































































































Intolerance of Uncertainty Scale – Short Form 
 
Your participation is voluntary. You do not have to complete any questions that you feel uncomfortable 
completing. 
 
Intolerance of Uncertainty Scale - Short Form 
 




Please circle the number that best corresponds to how much you agree with each item. 
















1. Unforeseen events upset me greatly. 
1 2 3 4 5 
 
2. It frustrates me not having all the 
information I need. 
3. Uncertainty keeps me from living a 
full life. 
4. One should always look ahead so as 
to avoid surprises. 
5. A small unforeseen event can spoil 
everything, even with the best of 
planning. 
6. When it’s time to act, uncertainty 
paralyses me. 
7. When I am uncertain I can’t function 
very well. 
8. I always want to know what the future 
has in store for me. 
 
1 2 3 4 5 
 
1 2 3 4 5 
 
1 2 3 4 5 
 
 
1 2 3 4 5 
 
 
1 2 3 4 5 
 
1 2 3 4 5 
 
1 2 3 4 5 
9. I can’t stand being taken by surprise. 
1 2 3 4 5 
 
10. The smallest doubt can stop me 
from acting. 
11. I should be able to organize 
everything in advance. 
12. I must get away from all uncertain 
situations. 
 
1 2 3 4 5 
 
1 2 3 4 5 
 
1 2 3 4 5 
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Penn State Worry Questionnaire (PSWQ) 
 









Circle the number that best describes how typical each item is of you over the past few weeks. 
 
 
1 = Not at all typical of me 
2 
3 = Somewhat typical of me 
4 





If I do not have enough time to do everything, I do not worry 
about it. 
 
2. My worries overwhelm me. 1 2 3 4 5 
 
3. I do not tend to worry about things. 1 2 3 4 5 
 
4. Many situations make me worry. 1 2 3 4 5 
 
5. I know I should not worry about things, but I just cannot help it. 1 2 3 4 5 
 
6. When I am under pressure I worry a lot. 1 2 3 4 5 
 
7. I am always worrying about something. 1 2 3 4 5 
 




As soon as I finish one task, I start to worry about everything 
else I have to do. 
 
10. I never worry about anything. 1 2 3 4 5 
 
11. When there is nothing more I can do about a concern, I do not 1 2 3 4 5 
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Your participation is voluntary. You do not have to complete any questions that you feel uncomfortable 
completing. 
 
The Cognition Checklist 
 
Please circle the number that best corresponds to often you have each thought: 
 
 Never Not 
very 
often 
Sometimes Often All of 
the 
time 
1. I’m worthless 1 2 3 4 5 
2. I will never overcome my 
problems 
1 2 3 4 5 
3. Life isn’t worth living 1 2 3 4 5 
4. There’s no one left to help me 1 2 3 4 5 
5.Nothing ever works out for me 1 2 3 4 5 
6. I have become physically 
unattractive 
1 2 3 4 5 
7. I’m not worthy of other people’s 
attention or affection 
1 2 3 4 5 
8. I don’t deserve to be loved 1 2 3 4 5 
9. People don’t respect me 
anymore 
1 2 3 4 5 
10. I’ve lost the only friends I had 1 2 3 4 5 
11. I’m worse off than they are 1 2 3 4 5 
12. No one cares whether I live or 
die 
1 2 3 4 5 
13. I’ll never be as good as other 
people are 
1 2 3 4 5 
14. I’m a social failure 1 2 3 4 5 
15. I’m going to have an accident 1 2 3 4 5 
16. There’s something very wrong 
with me 
1 2 3 4 5 
17. I am going to have a heart 
attack 
1 2 3 4 5 
18. Something awful is going to 
happen 
1 2 3 4 5 
19. Something will happen to 
someone I care about 
1 2 3 4 5 
20. I’m losing my mind 1 2 3 4 5 
21. What if I get sick and become 
disabled? 
1 2 3 4 5 
22. I am going to be injured 1 2 3 4 5 
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23. What if no one reaches me in 
time to help? 
1 2 3 4 5 
24. I might be trapped 1 2 3 4 5 
25. I am not a healthy person 1 2 3 4 5 
26. Something might happen that 
will ruin my appearance 
1 2 3 4 5 
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Appendix J Homework 
Compliance 






Please check the box that best describes you: 
 
□ I completed the homework every week 
 
□ I completed the homework for most of the weeks 
 
□ I completed the homework for some of the weeks 
 
□ I never completed the homework 

















Please check the boxes if the material was covered in this session: 
 
☐ Review of group rules and confidentiality 
 
☐ Introduction to group facilitators 
 
☐ Discussion of “what is anxiety” and recording of symptoms on the handouts 
 
☐ Introduction to the CBT model of anxiety 
 
☐ Psychoeducation on the role of breathing in anxiety 
 
☐ Abdominal breathing practice 
 
☐ Introduction to tracking cards 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    













Please check the boxes if the material was covered in this session: 
 
☐ Introduction of group facilitators 
 
☐ Review of group rules and confidentiality 
 
☐ Homework discussion while integrating a review of the breathing technique 
 
☐ Review of anxiety symptoms and how they relate to treatment targets 
 
☐ Discussion about the developmental conceptualizations of anxiety and worksheet 
completed 
☐ Psychoeducation on tension 
 
☐ Progressive muscle relaxation practice 
 
☐ Brief introduction to behaviours that will be focused on in later sessions 
 
☐ Review tracking card 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    













Please check the boxes if the material was covered in this session: 
 
☐ Homework reviewed with each person 
 
☐ Introduction to focusing on behaviours 
 
☐ Discussion of advantages/disadvantages of maintaining anxiety and practising 
strategies 
☐ Motivational interviewing techniques used to identify barriers to change 
 
☐ Psychoeducation on role exposure, and exposure handout used 
 
☐ Example of creating an exposure hierarchy 
 
☐ Clients create their own hierarchy using a handout 
 
☐ Situational exposure diary created 
 
☐ Tracking card reviewed 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    













Please check the boxes if the material was covered in this session: 
 
☐ Review of the homework 
 
☐ Problem solve regarding exposure hierarchy development 
 
☐ Psychoeducation on beginning exposure tasks 
 
☐ Review of the Situational Exposure Diary 
 
☐ Autogenic relaxation 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    













Please check the boxes if the material was covered in this session: 
 
☐ Review of the homework 
 
☐ Psychoeducation on exposure to internal sensations using handout 
 
☐ Exposure to internal sensations practice 
 
☐ Introduction to anxiety-related thoughts 
 
☐ Introduction to unhelpful thinking styles 
 
☐Use of the Unhelpful Thinking Style handout 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    













Please check the boxes if the material was covered in this session: 
 
☐ Discuss homework practice 
 
☐ Review of Unhelpful Thinking Styles 
 
☐ Introduction to ways of managing unhelpful thoughts 
 
☐ Psychoeducation of changing and analyzing thoughts 
 
☐Introduction to thought diary 
 
☐Work through thought record examples on the board 
 
☐Practice relaxation strategy 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    













Please check the boxes if the material was covered in this session: 
 
☐ Review of the homework 
 
☐ Review example of thought diary 
 
☐Psychoeducation on mindfulness approach to managing thoughts and worries 
 
☐Leaves on a stream mindfulness practice 
 
☐Psychoeducation on postponing worry 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    













Please check the boxes if the material was covered in this session: 
 
☐ Review of the homework: 
 
☐ Review of mindfulness 
 
☐ Review of worry scheduling 
 
☐ Jeopardy review game 
 
☐ Discussion of anxiety symptoms and strategies for each symptom 
 
☐ Certificates presented 
 





Please check the box that best describes the order of therapy components: 
 
☐ The session followed the treatment protocol 
 
☐ The session mostly followed the treatment protocol 
 
☐ The session somewhat followed the treatment protocol 
 





How many clients attended this session?    
